pubid,preferred,year,date,title,name,name_1,type,research_orgs,times_cited,recent_citations,score,country,state,city,latitude,longitude,country_code,state_code
pub.1125686004,The proximal origin of SARS-CoV-2,2020,2020-03-17,Nature Medicine,Columbia University,Springer Nature,article,"[grid.505518.c,grid.21729.3f,grid.265219.b,grid.214007.0,grid.1013.3,grid.4305.2]",2716,2710,36466,United States,New York,New York,40.807598114013672,-73.962387084960938,US,US-NY
pub.1125686004,The proximal origin of SARS-CoV-2,2020,2020-03-17,Nature Medicine,Scripps Research Institute,Springer Nature,article,"[grid.505518.c,grid.21729.3f,grid.265219.b,grid.214007.0,grid.1013.3,grid.4305.2]",2716,2710,36466,United States,California,San Diego,32.896213531494141,-117.24085998535156,US,US-CA
pub.1125686004,The proximal origin of SARS-CoV-2,2020,2020-03-17,Nature Medicine,University of Edinburgh,Springer Nature,article,"[grid.505518.c,grid.21729.3f,grid.265219.b,grid.214007.0,grid.1013.3,grid.4305.2]",2716,2710,36466,United Kingdom,,Edinburgh,55.944896697998047,-3.189284086227417,GB,
pub.1125686004,The proximal origin of SARS-CoV-2,2020,2020-03-17,Nature Medicine,Zalgen (United States),Springer Nature,article,"[grid.505518.c,grid.21729.3f,grid.265219.b,grid.214007.0,grid.1013.3,grid.4305.2]",2716,2710,36466,United States,Maryland,Germantown,39.187908172607422,-77.250335693359375,US,US-MD
pub.1125686004,The proximal origin of SARS-CoV-2,2020,2020-03-17,Nature Medicine,University of Sydney,Springer Nature,article,"[grid.505518.c,grid.21729.3f,grid.265219.b,grid.214007.0,grid.1013.3,grid.4305.2]",2716,2710,36466,Australia,New South Wales,Sydney,-33.888580322265625,151.18730163574219,AU,AU-NSW
pub.1125686004,The proximal origin of SARS-CoV-2,2020,2020-03-17,Nature Medicine,Tulane University,Springer Nature,article,"[grid.505518.c,grid.21729.3f,grid.265219.b,grid.214007.0,grid.1013.3,grid.4305.2]",2716,2710,36466,United States,Louisiana,New Orleans,29.939493179321289,-90.122276306152344,US,US-LA
pub.1140641988,Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections,2021,2021-08-25,medRxiv,Tel Aviv University,Cold Spring Harbor Laboratory,preprint,"[grid.12136.37,grid.425380.8]",56,56,34575,Israel,,Tel Aviv,32.113388061523438,34.802154541015625,IL,
pub.1140641988,Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections,2021,2021-08-25,medRxiv,Maccabi Institute for Health Services Research,Cold Spring Harbor Laboratory,preprint,"[grid.12136.37,grid.425380.8]",56,56,34575,Israel,,Tel Aviv,32.08001708984375,34.791061401367188,IL,
pub.1132688603,Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers,2020,2020-11-18,ACP Journal Club,Rigshospitalet,American College of Physicians,article,"[grid.414092.a,grid.6203.7,grid.4973.9,grid.475435.4,grid.5170.3]",133,133,30548,Denmark,,Copenhagen,55.696079254150391,12.566587448120117,DK,
pub.1132688603,Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers,2020,2020-11-18,ACP Journal Club,Copenhagen University Hospital,American College of Physicians,article,"[grid.414092.a,grid.6203.7,grid.4973.9,grid.475435.4,grid.5170.3]",133,133,30548,Denmark,,Copenhagen,55.697971343994141,12.565690994262695,DK,
pub.1132688603,Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers,2020,2020-11-18,ACP Journal Club,Statens Serum Institut,American College of Physicians,article,"[grid.414092.a,grid.6203.7,grid.4973.9,grid.475435.4,grid.5170.3]",133,133,30548,Denmark,Hovedstaden,Copenhagen,55.666000366210938,12.590999603271484,DK,DK-84
pub.1132688603,Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers,2020,2020-11-18,ACP Journal Club,Technical University of Denmark,American College of Physicians,article,"[grid.414092.a,grid.6203.7,grid.4973.9,grid.475435.4,grid.5170.3]",133,133,30548,Denmark,Hovedstaden,Kongens Lyngby,55.785797119140625,12.521533012390137,DK,DK-84
pub.1132688603,Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers,2020,2020-11-18,ACP Journal Club,Nordsjællands Hospital,American College of Physicians,article,"[grid.414092.a,grid.6203.7,grid.4973.9,grid.475435.4,grid.5170.3]",133,133,30548,Denmark,,Hillerød,55.930839538574219,12.32647705078125,DK,
pub.1139010213,"Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines",2021,2021-06-21,American Journal of Therapeutics,Newcastle University,Wolters Kluwer,article,"[grid.1006.7,grid.416994.7]",54,54,30332,United Kingdom,,Newcastle upon Tyne,54.978000640869141,-1.6150000095367432,GB,
pub.1139010213,"Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines",2021,2021-06-21,American Journal of Therapeutics,Ulster Hospital,Wolters Kluwer,article,"[grid.1006.7,grid.416994.7]",54,54,30332,United Kingdom,,Dundonald,54.597011566162109,-5.8115139007568359,GB,
pub.1135061524,Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia,2021,2021-02-02,The Lancet,Sechenov University,Elsevier,article,"[grid.77642.30,grid.494808.9,grid.415738.c,grid.448878.f]",623,623,28347,Russia,,Moscow,55.728057861328125,37.575000762939453,RU,
pub.1135061524,Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia,2021,2021-02-02,The Lancet,Ministry of Health,Elsevier,article,"[grid.77642.30,grid.494808.9,grid.415738.c,grid.448878.f]",623,623,28347,Russia,,Moscow,55.765262603759766,37.618602752685547,RU,
pub.1135061524,Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia,2021,2021-02-02,The Lancet,Peoples' Friendship University of Russia,Elsevier,article,"[grid.77642.30,grid.494808.9,grid.415738.c,grid.448878.f]",623,623,28347,Russia,,Moscow,55.650699615478516,37.5019416809082,RU,
pub.1135061524,Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia,2021,2021-02-02,The Lancet,Ministry of Defence of the Russian Federation,Elsevier,article,"[grid.77642.30,grid.494808.9,grid.415738.c,grid.448878.f]",623,623,28347,Russia,,Moscow,55.750144958496094,37.6024055480957,RU,
pub.1142678035,COVID-19: stigmatising the unvaccinated is not justified,2021,2021-11-18,The Lancet,University of Greifswald,Elsevier,article,[grid.5603.0],0,0,26978,Germany,,Greifswald,54.094638824462891,13.374625205993652,DE,
pub.1133379610,Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine,2020,2020-12-10,New England Journal of Medicine,Pfizer (United States),Massachusetts Medical Society,article,[grid.410513.2],4772,4771,26443,United States,New York,New York,40.750362396240234,-73.972541809082031,US,US-NY
pub.1141511087,Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States,2021,2021-09-30,European Journal of Epidemiology,Harvard University,Springer Nature,article,[grid.38142.3c],15,15,26226,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1125718014,Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1,2020,2020-03-17,New England Journal of Medicine,National Institute of Allergy and Infectious Diseases,Massachusetts Medical Society,article,"[grid.419681.3,grid.19006.3e,grid.16750.35,grid.416738.f]",5286,5282,25499,United States,Maryland,Bethesda,39.066646575927734,-77.111831665039062,US,US-MD
pub.1125718014,Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1,2020,2020-03-17,New England Journal of Medicine,Princeton University,Massachusetts Medical Society,article,"[grid.419681.3,grid.19006.3e,grid.16750.35,grid.416738.f]",5286,5282,25499,United States,New Jersey,Princeton,40.344234466552734,-74.6514663696289,US,US-NJ
pub.1125718014,Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1,2020,2020-03-17,New England Journal of Medicine,Centers for Disease Control and Prevention,Massachusetts Medical Society,article,"[grid.419681.3,grid.19006.3e,grid.16750.35,grid.416738.f]",5286,5282,25499,United States,Georgia,Atlanta,33.7988166809082,-84.325599670410156,US,US-GA
pub.1125718014,Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1,2020,2020-03-17,New England Journal of Medicine,"University of California, Los Angeles",Massachusetts Medical Society,article,"[grid.419681.3,grid.19006.3e,grid.16750.35,grid.416738.f]",5286,5282,25499,United States,California,Los Angeles,34.072223663330078,-118.44409942626953,US,US-CA
pub.1128115677,"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis",2020,2020-06-01,The Lancet,McMaster University,Elsevier,article,"[grid.25073.33,grid.22903.3a]",1910,1910,24526,Canada,Ontario,Hamilton,43.263332366943359,-79.918891906738281,CA,CA-ON
pub.1128115677,"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis",2020,2020-06-01,The Lancet,American University of Beirut,Elsevier,article,"[grid.25073.33,grid.22903.3a]",1910,1910,24526,Lebanon,,Beirut,33.901092529296875,35.481529235839844,LB,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,Huazhong University of Science and Technology,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,China,,Wuhan,30.508182525634766,114.41474151611328,CN,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,La Trobe University,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,Australia,Victoria,Melbourne,-37.7217903137207,145.04791259765625,AU,AU-VIC
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,University of Melbourne,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,Australia,Victoria,Melbourne,-37.797115325927734,144.95997619628906,AU,AU-VIC
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,Jiangxi Science and Technology Normal University,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,China,,Nanchang,28.664638519287109,115.82196807861328,CN,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,Zhengzhou University,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,China,,Zhengzhou,34.816024780273438,113.5357666015625,CN,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,Tongji Hospital,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,China,,Wuhan,30.578750610351562,114.26175689697266,CN,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,Hainan Medical University,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,China,,Haikou,19.981660842895508,110.33306121826172,CN,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,Wuhan Municipal Health Commission,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,China,,Jiang’an Qu,30.588815689086914,114.27989196777344,CN,
pub.1132770156,"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China",2020,2020-11-20,Nature Communications,University of East Anglia,Springer Nature,article,"[grid.1018.8,grid.508241.a,grid.33199.31,grid.411864.e,grid.207374.5,grid.412793.a,grid.8273.e,grid.1008.9,grid.443397.e]",87,87,23397,United Kingdom,Norfolk,Norwich,52.621665954589844,1.2416670322418213,GB,GB-NFK
pub.1142695987,The epidemiological relevance of the COVID-19-vaccinated population is increasing,2021,2021-11-20,The Lancet Regional Health - Europe,University of Greifswald,Elsevier,article,[grid.5603.0],1,1,23367,Germany,,Greifswald,54.094638824462891,13.374625205993652,DE,
pub.1127834352,RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-05-22,The Lancet,University Hospital of Zurich,Elsevier,article,"[grid.62560.37,grid.223827.e,grid.38142.3c,grid.414420.7,grid.412004.3]",670,670,22819,Switzerland,,Zurich,47.376667022705078,8.5497217178344727,CH,
pub.1127834352,RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-05-22,The Lancet,Hospital Corporation of America,Elsevier,article,"[grid.62560.37,grid.223827.e,grid.38142.3c,grid.414420.7,grid.412004.3]",670,670,22819,United States,Tennessee,Nashville,36.153732299804688,-86.813774108886719,US,US-TN
pub.1127834352,RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-05-22,The Lancet,Harvard University,Elsevier,article,"[grid.62560.37,grid.223827.e,grid.38142.3c,grid.414420.7,grid.412004.3]",670,670,22819,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1127834352,RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-05-22,The Lancet,Brigham and Women's Hospital,Elsevier,article,"[grid.62560.37,grid.223827.e,grid.38142.3c,grid.414420.7,grid.412004.3]",670,670,22819,United States,Massachusetts,Boston,42.335601806640625,-71.106414794921875,US,US-MA
pub.1127834352,RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-05-22,The Lancet,University of Utah,Elsevier,article,"[grid.62560.37,grid.223827.e,grid.38142.3c,grid.414420.7,grid.412004.3]",670,670,22819,United States,Utah,Salt Lake City,40.764961242675781,-111.84214782714844,US,US-UT
pub.1137233109,Ten scientific reasons in support of airborne transmission of SARS-CoV-2,2021,2021-04-15,The Lancet,University of North Carolina System,Elsevier,article,"[grid.4991.5,grid.266190.a,grid.410711.2,grid.17063.33,grid.266100.3]",225,225,21585,United States,North Carolina,Chapel Hill,35.904914855957031,-79.046920776367188,US,US-NC
pub.1137233109,Ten scientific reasons in support of airborne transmission of SARS-CoV-2,2021,2021-04-15,The Lancet,"University of California, San Diego",Elsevier,article,"[grid.4991.5,grid.266190.a,grid.410711.2,grid.17063.33,grid.266100.3]",225,225,21585,United States,California,San Diego,32.881000518798828,-117.23799896240234,US,US-CA
pub.1137233109,Ten scientific reasons in support of airborne transmission of SARS-CoV-2,2021,2021-04-15,The Lancet,University of Toronto,Elsevier,article,"[grid.4991.5,grid.266190.a,grid.410711.2,grid.17063.33,grid.266100.3]",225,225,21585,Canada,Ontario,Toronto,43.661666870117188,-79.3949966430664,CA,CA-ON
pub.1137233109,Ten scientific reasons in support of airborne transmission of SARS-CoV-2,2021,2021-04-15,The Lancet,University of Oxford,Elsevier,article,"[grid.4991.5,grid.266190.a,grid.410711.2,grid.17063.33,grid.266100.3]",225,225,21585,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1137233109,Ten scientific reasons in support of airborne transmission of SARS-CoV-2,2021,2021-04-15,The Lancet,University of Colorado Boulder,Elsevier,article,"[grid.4991.5,grid.266190.a,grid.410711.2,grid.17063.33,grid.266100.3]",225,225,21585,United States,Colorado,Boulder,40.007366180419922,-105.2652587890625,US,US-CO
pub.1126104118,The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro,2020,2020-04-03,Antiviral Research,Monash University,Elsevier,article,[grid.1002.3],1069,1068,21504,Australia,Victoria,Melbourne,-37.908298492431641,145.13800048828125,AU,AU-VIC
pub.1128424445,Identifying airborne transmission as the dominant route for the spread of COVID-19,2020,2020-06-11,Proceedings of the National Academy of Sciences of the United States of America,Texas A&M University,Proceedings of the National Academy of Sciences,article,"[grid.264756.4,grid.20861.3d,grid.89336.37,grid.266100.3]",601,601,21317,United States,Texas,College Station,30.610368728637695,-96.34405517578125,US,US-TX
pub.1128424445,Identifying airborne transmission as the dominant route for the spread of COVID-19,2020,2020-06-11,Proceedings of the National Academy of Sciences of the United States of America,"University of California, San Diego",Proceedings of the National Academy of Sciences,article,"[grid.264756.4,grid.20861.3d,grid.89336.37,grid.266100.3]",601,601,21317,United States,California,San Diego,32.881000518798828,-117.23799896240234,US,US-CA
pub.1128424445,Identifying airborne transmission as the dominant route for the spread of COVID-19,2020,2020-06-11,Proceedings of the National Academy of Sciences of the United States of America,The University of Texas at Austin,Proceedings of the National Academy of Sciences,article,"[grid.264756.4,grid.20861.3d,grid.89336.37,grid.266100.3]",601,601,21317,United States,Texas,Austin,30.286140441894531,-97.739418029785156,US,US-TX
pub.1128424445,Identifying airborne transmission as the dominant route for the spread of COVID-19,2020,2020-06-11,Proceedings of the National Academy of Sciences of the United States of America,California Institute of Technology,Proceedings of the National Academy of Sciences,article,"[grid.264756.4,grid.20861.3d,grid.89336.37,grid.266100.3]",601,601,21317,United States,California,Pasadena,34.138576507568359,-118.12549591064453,US,US-CA
pub.1140083857,"Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021",2021,2021-08-06,MMWR Morbidity and Mortality Weekly Report,Massachusetts Department of Public Health,Centers for Disease Control MMWR Office,article,[grid.416511.6],170,170,21011,United States,Massachusetts,Boston,42.358070373535156,-71.0577163696289,US,US-MA
pub.1126105928,Respiratory virus shedding in exhaled breath and efficacy of face masks,2020,2020-04-03,Nature Medicine,Queen Mary Hospital,Springer Nature,article,"[grid.194645.b,grid.415550.0,grid.38142.3c,grid.460833.a,grid.164295.d]",1158,1157,20968,China,Hong Kong,Hong Kong,22.270059585571289,114.13114929199219,CN,CN-91
pub.1126105928,Respiratory virus shedding in exhaled breath and efficacy of face masks,2020,2020-04-03,Nature Medicine,University of Hong Kong,Springer Nature,article,"[grid.194645.b,grid.415550.0,grid.38142.3c,grid.460833.a,grid.164295.d]",1158,1157,20968,China,Hong Kong,Hong Kong,22.283287048339844,114.13707733154297,CN,CN-91
pub.1126105928,Respiratory virus shedding in exhaled breath and efficacy of face masks,2020,2020-04-03,Nature Medicine,"University of Maryland, College Park",Springer Nature,article,"[grid.194645.b,grid.415550.0,grid.38142.3c,grid.460833.a,grid.164295.d]",1158,1157,20968,United States,Maryland,College Park,38.983047485351562,-76.941864013671875,US,US-MD
pub.1126105928,Respiratory virus shedding in exhaled breath and efficacy of face masks,2020,2020-04-03,Nature Medicine,Hong Kong Baptist Hospital,Springer Nature,article,"[grid.194645.b,grid.415550.0,grid.38142.3c,grid.460833.a,grid.164295.d]",1158,1157,20968,China,,Hong Kong,22.339624404907227,114.18015289306641,CN,
pub.1126105928,Respiratory virus shedding in exhaled breath and efficacy of face masks,2020,2020-04-03,Nature Medicine,Harvard University,Springer Nature,article,"[grid.194645.b,grid.415550.0,grid.38142.3c,grid.460833.a,grid.164295.d]",1158,1157,20968,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1137352852,Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons,2021,2021-04-21,New England Journal of Medicine,Center for Biologics Evaluation and Research,Massachusetts Medical Society,article,[grid.290496.0],225,225,19916,United States,Maryland,Silver Spring,39.035507202148438,-76.9828109741211,US,US-MD
pub.1132052395,Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease,2020,2020-12-04,International Journal of Clinical Practice,Tulane University,Wiley,article,"[grid.240324.3,grid.265219.b]",8,8,19856,United States,Louisiana,New Orleans,29.939493179321289,-90.122276306152344,US,US-LA
pub.1132052395,Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease,2020,2020-12-04,International Journal of Clinical Practice,New York University Langone Medical Center,Wiley,article,"[grid.240324.3,grid.265219.b]",8,8,19856,United States,New York,New York,40.741970062255859,-73.974029541015625,US,US-NY
pub.1132837551,Facemasks in the COVID-19 era: A health hypothesis,2020,2020-11-22,Medical Hypotheses,Stanford University,Elsevier,article,[grid.168010.e],10,10,19796,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1128249398,Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-06-05,The Lancet,University of Utah,Elsevier,article,"[grid.414420.7,grid.38142.3c,grid.62560.37,grid.223827.e,grid.412004.3]",357,357,19525,United States,Utah,Salt Lake City,40.764961242675781,-111.84214782714844,US,US-UT
pub.1128249398,Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-06-05,The Lancet,Hospital Corporation of America,Elsevier,article,"[grid.414420.7,grid.38142.3c,grid.62560.37,grid.223827.e,grid.412004.3]",357,357,19525,United States,Tennessee,Nashville,36.153732299804688,-86.813774108886719,US,US-TN
pub.1128249398,Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-06-05,The Lancet,Harvard University,Elsevier,article,"[grid.414420.7,grid.38142.3c,grid.62560.37,grid.223827.e,grid.412004.3]",357,357,19525,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1128249398,Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-06-05,The Lancet,Brigham and Women's Hospital,Elsevier,article,"[grid.414420.7,grid.38142.3c,grid.62560.37,grid.223827.e,grid.412004.3]",357,357,19525,United States,Massachusetts,Boston,42.335601806640625,-71.106414794921875,US,US-MA
pub.1128249398,Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,2020,2020-06-05,The Lancet,University Hospital of Zurich,Elsevier,article,"[grid.414420.7,grid.38142.3c,grid.62560.37,grid.223827.e,grid.412004.3]",357,357,19525,Switzerland,,Zurich,47.376667022705078,8.5497217178344727,CH,
pub.1126667003,Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period,2020,2020-04-14,Science,Harvard University,American Association for the Advancement of Science (AAAS),article,[grid.38142.3c],1717,1716,18900,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1142236059,"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study",2021,2021-10-29,The Lancet Infectious Diseases,University of Oxford,Elsevier,article,"[grid.462482.e,grid.271308.f,grid.511288.7,grid.4991.5,grid.7445.2]",53,53,18426,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1142236059,"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study",2021,2021-10-29,The Lancet Infectious Diseases,Imperial College London,Elsevier,article,"[grid.462482.e,grid.271308.f,grid.511288.7,grid.4991.5,grid.7445.2]",53,53,18426,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1142236059,"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study",2021,2021-10-29,The Lancet Infectious Diseases,Public Health England,Elsevier,article,"[grid.462482.e,grid.271308.f,grid.511288.7,grid.4991.5,grid.7445.2]",53,53,18426,United Kingdom,,London,51.691043853759766,-0.11340100318193436,GB,
pub.1142236059,"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study",2021,2021-10-29,The Lancet Infectious Diseases,Manchester Academic Health Science Centre,Elsevier,article,"[grid.462482.e,grid.271308.f,grid.511288.7,grid.4991.5,grid.7445.2]",53,53,18426,United Kingdom,,Manchester,53.463275909423828,-2.2384340763092041,GB,
pub.1142236059,"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study",2021,2021-10-29,The Lancet Infectious Diseases,London Biofoundry,Elsevier,article,"[grid.462482.e,grid.271308.f,grid.511288.7,grid.4991.5,grid.7445.2]",53,53,18426,United Kingdom,,London,51.515777587890625,-0.22449059784412384,GB,
pub.1137340253,COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room,2021,2021-04-20,The Lancet Microbe,University of Oxford,Elsevier,article,"[grid.451012.3,grid.83440.3b,grid.4991.5]",48,48,18180,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1137340253,COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room,2021,2021-04-20,The Lancet Microbe,University College London,Elsevier,article,"[grid.451012.3,grid.83440.3b,grid.4991.5]",48,48,18180,United Kingdom,,London,51.524471282958984,-0.13398170471191406,GB,
pub.1137340253,COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room,2021,2021-04-20,The Lancet Microbe,Luxembourg Institute of Health,Elsevier,article,"[grid.451012.3,grid.83440.3b,grid.4991.5]",48,48,18180,Luxembourg,,Strassen,49.619960784912109,6.095944881439209,LU,
pub.1134321239,Assessing mandatory stay‐at‐home and business closure effects on the spread of COVID‐19,2021,2021-02,European Journal of Clinical Investigation,Stanford University,Wiley,article,[grid.168010.e],74,74,18165,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1126094786,"COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020",2020,2020-04-02,Emerging Infectious Diseases,Guangzhou Center for Disease Control and Prevention,Centers for Disease Control and Prevention (CDC),article,[grid.508371.8],502,502,17619,China,,Guangzhou,23.230728149414062,113.2877197265625,CN,
pub.1139835539,Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant,2021,2021-07-21,New England Journal of Medicine,Royal Marsden Hospital,Massachusetts Medical Society,article,[grid.424926.f],677,677,17440,United Kingdom,,London,51.491279602050781,-0.17258299887180328,GB,
pub.1127950373,Reducing transmission of SARS-CoV-2,2020,2020-05-27,Science,Scripps Institution of Oceanography,American Association for the Advancement of Science (AAAS),article,"[grid.412036.2,grid.266100.3,grid.217200.6]",433,433,17276,United States,California,La Jolla,32.865436553955078,-117.25362396240234,US,US-CA
pub.1127950373,Reducing transmission of SARS-CoV-2,2020,2020-05-27,Science,National Sun Yat-sen University,American Association for the Advancement of Science (AAAS),article,"[grid.412036.2,grid.266100.3,grid.217200.6]",433,433,17276,Taiwan,,Kaohsiung City,22.626667022705078,120.26583099365234,TW,
pub.1127950373,Reducing transmission of SARS-CoV-2,2020,2020-05-27,Science,"University of California, San Diego",American Association for the Advancement of Science (AAAS),article,"[grid.412036.2,grid.266100.3,grid.217200.6]",433,433,17276,United States,California,San Diego,32.881000518798828,-117.23799896240234,US,US-CA
pub.1126759322,"COVID-19 Antibody Seroprevalence in Santa Clara County, California",2020,2020-04-17,medRxiv,Stanford University,Cold Spring Harbor Laboratory,preprint,[grid.168010.e],410,410,16675,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1126655280,Temporal dynamics in viral shedding and transmissibility of COVID-19,2020,2020-04-15,Nature Medicine,University of Hong Kong,Springer Nature,article,"[grid.194645.b,grid.410737.6]",2829,2829,16470,China,Hong Kong,Hong Kong,22.283287048339844,114.13707733154297,CN,CN-91
pub.1126655280,Temporal dynamics in viral shedding and transmissibility of COVID-19,2020,2020-04-15,Nature Medicine,Guangzhou Medical University,Springer Nature,article,"[grid.194645.b,grid.410737.6]",2829,2829,16470,China,Guangdong,Guangzhou,23.136238098144531,113.25353240966797,CN,CN-44
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Brown University,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,Rhode Island,Providence,41.826198577880859,-71.4031982421875,US,US-RI
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Hong Kong Baptist University,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,China,,Hong Kong,22.338165283203125,114.18193817138672,CN,
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,University of San Francisco,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,California,San Francisco,37.779445648193359,-122.45194244384766,US,US-CA
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,"University of California, Los Angeles",Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,California,Los Angeles,34.072223663330078,-118.44409942626953,US,US-CA
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Peking University,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,China,Beijing,Beijing,39.987152099609375,116.30585479736328,CN,CN-11
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Stanford University,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,University of Pennsylvania,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,Pennsylvania,Philadelphia,39.952457427978516,-75.193222045898438,US,US-PA
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Hong Kong University of Science and Technology,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,China,Hong Kong,Hong Kong,22.336181640625,114.26512145996094,CN,CN-91
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,University of Cape Town,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,South Africa,,Rondebosch,-33.957500457763672,18.460556030273438,ZA,
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Massachusetts Institute of Technology,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,Massachusetts,Cambridge,42.359821319580078,-71.092109680175781,US,US-MA
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Beijing Computational Science Research Center,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,China,,Beijing,39.914325714111328,116.38093566894531,CN,
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,University of North Carolina at Chapel Hill,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United States,North Carolina,Chapel Hill,35.9051628112793,-79.046943664550781,US,US-NC
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,University of Oxford,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Vrije Universiteit Brussel,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,Belgium,,Brussels,50.823200225830078,4.3925881385803223,BE,
pub.1134494211,An evidence review of face masks against COVID-19,2021,2021-01-11,Proceedings of the National Academy of Sciences of the United States of America,Czech Academy of Sciences,Proceedings of the National Academy of Sciences,article,"[grid.11135.37,grid.221309.b,grid.10698.36,grid.267103.1,grid.116068.8,grid.24515.37,grid.410743.5,grid.168010.e,grid.4991.5,grid.25879.31,grid.8767.e,grid.40263.33,grid.418095.1,grid.7836.a,grid.19006.3e]",235,235,16380,Czechia,,Prague,50.081390380859375,14.414167404174805,CZ,
pub.1137733034,Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19,2021,2021-04-22,American Journal of Therapeutics,The University of Texas Health Science Center at Houston,Wolters Kluwer,article,"[grid.267301.1,grid.267308.8,grid.255414.3,grid.413847.d]",48,48,16325,United States,Texas,Houston,29.703306198120117,-95.4030532836914,US,US-TX
pub.1137733034,Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19,2021,2021-04-22,American Journal of Therapeutics,Eastern Virginia Medical School,Wolters Kluwer,article,"[grid.267301.1,grid.267308.8,grid.255414.3,grid.413847.d]",48,48,16325,United States,Virginia,Norfolk,36.860122680664062,-76.30096435546875,US,US-VA
pub.1137733034,Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19,2021,2021-04-22,American Journal of Therapeutics,Memphis VA Medical Center,Wolters Kluwer,article,"[grid.267301.1,grid.267308.8,grid.255414.3,grid.413847.d]",48,48,16325,United States,Tennessee,Memphis,35.144321441650391,-90.0262451171875,US,US-TN
pub.1137733034,Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19,2021,2021-04-22,American Journal of Therapeutics,University of Tennessee Health Science Center,Wolters Kluwer,article,"[grid.267301.1,grid.267308.8,grid.255414.3,grid.413847.d]",48,48,16325,United States,Tennessee,Memphis,35.139572143554688,-90.0301513671875,US,US-TN
pub.1144086196,Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study,2021,2021-12-21,medRxiv,Statens Serum Institut,Cold Spring Harbor Laboratory,preprint,[grid.6203.7],6,6,16319,Denmark,Hovedstaden,Copenhagen,55.666000366210938,12.590999603271484,DK,DK-84
pub.1140147868,"Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19",2021,2021-08-03,New Microbes and New Infections,Centre For Digestive Diseases,Elsevier,article,"[grid.492342.a,grid.47100.32,grid.264756.4,grid.410786.c]",1,1,16292,Australia,New South Wales,Five Dock,-33.865104675292969,151.12997436523438,AU,AU-NSW
pub.1140147868,"Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19",2021,2021-08-03,New Microbes and New Infections,Yale University,Elsevier,article,"[grid.492342.a,grid.47100.32,grid.264756.4,grid.410786.c]",1,1,16292,United States,Connecticut,New Haven,41.302093505859375,-72.930656433105469,US,US-CT
pub.1140147868,"Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19",2021,2021-08-03,New Microbes and New Infections,Texas A&M University,Elsevier,article,"[grid.492342.a,grid.47100.32,grid.264756.4,grid.410786.c]",1,1,16292,United States,Texas,College Station,30.610368728637695,-96.34405517578125,US,US-TX
pub.1140147868,"Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19",2021,2021-08-03,New Microbes and New Infections,Kitasato University,Elsevier,article,"[grid.492342.a,grid.47100.32,grid.264756.4,grid.410786.c]",1,1,16292,Japan,,Tokyo,35.642559051513672,139.72563171386719,JP,
pub.1125685505,Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2),2020,2020-03-16,Science,Tsinghua University,American Association for the Advancement of Science (AAAS),article,"[grid.27860.3b,grid.194645.b,grid.21729.3f,grid.12527.33,grid.7445.2]",2400,2400,16274,China,Beijing,Beijing,39.999584197998047,116.32541656494141,CN,CN-11
pub.1125685505,Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2),2020,2020-03-16,Science,Imperial College London,American Association for the Advancement of Science (AAAS),article,"[grid.27860.3b,grid.194645.b,grid.21729.3f,grid.12527.33,grid.7445.2]",2400,2400,16274,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1125685505,Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2),2020,2020-03-16,Science,University of Hong Kong,American Association for the Advancement of Science (AAAS),article,"[grid.27860.3b,grid.194645.b,grid.21729.3f,grid.12527.33,grid.7445.2]",2400,2400,16274,China,Hong Kong,Hong Kong,22.283287048339844,114.13707733154297,CN,CN-91
pub.1125685505,Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2),2020,2020-03-16,Science,Columbia University,American Association for the Advancement of Science (AAAS),article,"[grid.27860.3b,grid.194645.b,grid.21729.3f,grid.12527.33,grid.7445.2]",2400,2400,16274,United States,New York,New York,40.807598114013672,-73.962387084960938,US,US-NY
pub.1125685505,Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2),2020,2020-03-16,Science,"University of California, Davis",American Association for the Advancement of Science (AAAS),article,"[grid.27860.3b,grid.194645.b,grid.21729.3f,grid.12527.33,grid.7445.2]",2400,2400,16274,United States,California,Davis,38.540000915527344,-121.75,US,US-CA
pub.1130340155,Two metres or one: what is the evidence for physical distancing in covid-19?,2020,2020-08-25,The BMJ,St Thomas' Hospital,BMJ,article,"[grid.4991.5,grid.116068.8,grid.425213.3]",177,177,15789,United Kingdom,,London,51.498817443847656,-0.11910080909729004,GB,
pub.1130340155,Two metres or one: what is the evidence for physical distancing in covid-19?,2020,2020-08-25,The BMJ,University of Oxford,BMJ,article,"[grid.4991.5,grid.116068.8,grid.425213.3]",177,177,15789,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1130340155,Two metres or one: what is the evidence for physical distancing in covid-19?,2020,2020-08-25,The BMJ,Massachusetts Institute of Technology,BMJ,article,"[grid.4991.5,grid.116068.8,grid.425213.3]",177,177,15789,United States,Massachusetts,Cambridge,42.359821319580078,-71.092109680175781,US,US-MA
pub.1130541657,Low-cost measurement of face mask efficacy for filtering expelled droplets during speech,2020,2020-09-02,Science Advances,Duke University,American Association for the Advancement of Science (AAAS),article,[grid.26009.3d],165,165,15710,United States,North Carolina,Durham,36.003147125244141,-78.926895141601562,US,US-NC
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,Philipp University of Marburg,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,Germany,,Marburg,50.810832977294922,8.7736110687255859,DE,
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,University of Southampton,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,,Southampton,50.93463134765625,-1.3959499597549438,GB,
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,University of Oxford,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,University of Bristol,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,,Bristol,51.456390380859375,-2.6044440269470215,GB,
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,Public Health England,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,,London,51.691043853759766,-0.11340100318193436,GB,
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,NIHR Oxford Musculoskeletal Biomedical Research Centre,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,,Oxford,51.754344940185547,-1.2093130350112915,GB,
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,Imperial College London,Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1129493369,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",2020,2020-07-20,The Lancet,"St George's, University of London",Elsevier,article,"[grid.454382.c,grid.5491.9,grid.271308.f,grid.5337.2,grid.7445.2,grid.10253.35,grid.4991.5,grid.264200.2]",1234,1234,15501,United Kingdom,,London,51.427387237548828,-0.17451399564743042,GB,
pub.1139252270,Experimental Assessment of Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy Children,2021,2021-06-30,JAMA Pediatrics,Poznan University of Medical Sciences,American Medical Association (AMA),article,[grid.22254.33],2,2,15296,Poland,,Poznań,52.409442901611328,16.918888092041016,PL,
pub.1126753049,In Pursuit of PPE,2020,2020-04-17,New England Journal of Medicine,Baystate Health,Massachusetts Medical Society,article,[grid.476946.e],49,49,15024,United States,Massachusetts,Springfield,42.108737945556641,-72.594062805175781,US,US-MA
pub.1132629215,"Covid-19: politicisation, “corruption,” and suppression of science",2020,2020-11-13,The BMJ,British Medical Association,BMJ,article,[grid.431398.4],38,38,14997,United Kingdom,,London,51.525722503662109,-0.12857499718666077,GB,
pub.1129357618,An mRNA Vaccine against SARS-CoV-2 — Preliminary Report,2020,2020-07-14,New England Journal of Medicine,National Institute of Allergy and Infectious Diseases,Massachusetts Medical Society,article,[grid.419681.3],1627,1626,14644,United States,Maryland,Bethesda,39.066646575927734,-77.111831665039062,US,US-MD
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Huazhong University of Science and Technology,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Wuhan,30.508182525634766,114.41474151611328,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Peking University People's Hospital,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Beijing,39.937652587890625,116.35475921630859,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Center for Life Sciences,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Beijing,39.917293548583984,116.40158081054688,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Peking University First Hospital,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Beijing,39.932243347167969,116.381103515625,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,China-Japan Friendship Hospital,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Beijing,39.974925994873047,116.427001953125,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Tongji Hospital,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Wuhan,30.578750610351562,114.26175689697266,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Tsinghua University,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,Beijing,Beijing,39.999584197998047,116.32541656494141,CN,CN-11
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Capital Medical University,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Beijing,39.865432739257812,116.35283660888672,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Zhongnan Hospital of Wuhan University,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Wuhan,30.554094314575195,114.35368347167969,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Jinyintan Hospital,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Wuhan,30.66705322265625,114.28695678710938,CN,
pub.1124290823,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",2020,2020-01-24,The Lancet,Chinese Academy of Medical Sciences & Peking Union Medical College,Elsevier,article,"[grid.12527.33,grid.452723.5,grid.33199.31,grid.413247.7,grid.412793.a,grid.507952.c,grid.411472.5,grid.415954.8,grid.24696.3f,grid.506261.6,grid.411634.5]",26959,26930,14626,China,,Beijing,39.911491394042969,116.41478729248047,CN,
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,National Sun Yat-sen University,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,Taiwan,,Kaohsiung City,22.626667022705078,120.26583099365234,TW,
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,University of North Carolina System,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,United States,North Carolina,Chapel Hill,35.904914855957031,-79.046920776367188,US,US-NC
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,University of Colorado Boulder,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,United States,Colorado,Boulder,40.007366180419922,-105.2652587890625,US,US-CO
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,Virginia Tech,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,United States,Virginia,Blacksburg,37.220008850097656,-80.424087524414062,US,US-VA
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,Technion – Israel Institute of Technology,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,Israel,,Haifa,32.777500152587891,35.02166748046875,IL,
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,Scripps Institution of Oceanography,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,United States,California,La Jolla,32.865436553955078,-117.25362396240234,US,US-CA
pub.1140672843,Airborne transmission of respiratory viruses,2021,2021-08-27,Science,University of Pittsburgh,American Association for the Advancement of Science (AAAS),article,"[grid.217200.6,grid.412036.2,grid.266190.a,grid.6451.6,grid.410711.2,grid.438526.e,grid.21925.3d]",47,47,14310,United States,Pennsylvania,Pittsburgh,40.443504333496094,-79.9615249633789,US,US-PA
pub.1141870334,SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro,2021,2021-10-13,Viruses,Umeå University,MDPI,article,"[grid.12650.30,grid.10548.38]",2,2,14292,Sweden,,Umeå,63.821567535400391,20.310623168945312,SE,
pub.1141870334,SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro,2021,2021-10-13,Viruses,Stockholm University,MDPI,article,"[grid.12650.30,grid.10548.38]",2,2,14292,Sweden,,Stockholm,59.365276336669922,18.058332443237305,SE,
pub.1142404473,"Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021",2021,2021-11-05,MMWR Morbidity and Mortality Weekly Report,Regenstrief Institute,Centers for Disease Control MMWR Office,article,[grid.448342.d],9,9,14205,United States,Indiana,Indianapolis,39.781513214111328,-86.166885375976562,US,US-IN
pub.1129597854,Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19),2020,2020-11-01,JAMA Cardiology,University Hospital Frankfurt,American Medical Association (AMA),article,"[grid.448878.f,grid.411088.4,grid.10438.3e]",903,903,13944,Germany,,Frankfurt am Main,50.096473693847656,8.6613330841064453,DE,
pub.1129597854,Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19),2020,2020-11-01,JAMA Cardiology,University of Messina,American Medical Association (AMA),article,"[grid.448878.f,grid.411088.4,grid.10438.3e]",903,903,13944,Italy,,Messina,38.192691802978516,15.546197891235352,IT,
pub.1129597854,Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19),2020,2020-11-01,JAMA Cardiology,Sechenov University,American Medical Association (AMA),article,"[grid.448878.f,grid.411088.4,grid.10438.3e]",903,903,13944,Russia,,Moscow,55.728057861328125,37.575000762939453,RU,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Newcastle upon Tyne Hospitals NHS Foundation Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Newcastle upon Tyne,54.976863861083984,-1.6461999416351318,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Hull,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,Kingston upon Hull,Hull,53.770263671875,-0.3671410083770752,GB,GB-KHL
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Aneurin Bevan University Health Board,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Newport,51.613399505615234,-2.9671399593353271,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Southampton,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Southampton,50.93463134765625,-1.3959499597549438,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Hospital de Clínicas de Porto Alegre,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,Porto Alegre,-30.037975311279297,-51.207469940185547,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Cape Town,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,South Africa,,Rondebosch,-33.957500457763672,18.460556030273438,ZA,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of the Witwatersrand,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,South Africa,,Johannesburg,-26.190832138061523,28.030277252197266,ZA,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Soweto CTC,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,South Africa,,Soweto,-26.267045974731445,27.877719879150391,ZA,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,AstraZeneca (United Kingdom),Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Cambridge,51.519588470458984,-0.18164600431919098,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,St Thomas' Hospital,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,London,51.498817443847656,-0.11910080909729004,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,North Bristol NHS Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Bristol,51.498706817626953,-2.5943069458007812,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Newcastle University,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Newcastle upon Tyne,54.978000640869141,-1.6150000095367432,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Bristol,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Bristol,51.456390380859375,-2.6044440269470215,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,National Institute for Health Research,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,London,51.502704620361328,-0.12534999847412109,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Federal University of Rio Grande do Norte,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,Natal,-5.8393106460571289,-35.2001953125,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Western General Hospital,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,Scotland,Edinburgh,55.963272094726562,-3.2327098846435547,GB,GB-SCT
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Universidade Unigranrio,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,Rio de Janeiro,-22.981395721435547,-43.367530822753906,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,D’Or Institute for Research and Education,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,Rio de Janeiro,-22.958524703979492,-43.192276000976562,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Universidade Federal de Santa Maria,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,Santa Maria,-29.71351432800293,-53.716171264648438,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University Hospital Southampton NHS Foundation Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Southampton,50.934852600097656,-1.4339799880981445,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Glasgow,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Glasgow,55.872306823730469,-4.2882208824157715,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Papworth Hospital NHS Foundation Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Cambridge,52.2480583190918,-0.11077000200748444,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Federal University of São Paulo,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,São Paulo,-23.591619491577148,-46.649024963378906,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Public Health Wales,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Cardiff,51.476806640625,-3.1695449352264404,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Sheffield Teaching Hospitals NHS Foundation Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Sheffield,53.376457214355469,-1.4888850450515747,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Cambridge University Hospitals NHS Foundation Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Cambridge,52.174381256103516,0.141292005777359,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Federal University of Rio Grande do Sul,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,Rio Grande do Sul,Porto Alegre,-30.032438278198242,-51.219314575195312,BR,BR-RS
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Escola Bahiana de Medicina e Saúde Pública,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,Brazil,,Salvador,-12.958910942077637,-38.452560424804688,BR,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,NIHR Imperial Biomedical Research Centre,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,London,51.518100738525391,-0.17687800526618958,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Setshaba Research Centre,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,South Africa,,Pretoria,-25.526166915893555,28.10847282409668,ZA,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Oxford,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,London School of Hygiene & Tropical Medicine,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,Camden,London,51.520900726318359,-0.1307000070810318,GB,GB-CMD
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Cambridge,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Cambridge,52.204452514648438,0.11490800231695175,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University Hospitals Birmingham NHS Foundation Trust,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Birmingham,52.451278686523438,-1.9413900375366211,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Sheffield,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Sheffield,53.381389617919922,-1.488271951675415,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,"St George's, University of London",Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,London,51.427387237548828,-0.17451399564743042,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Stellenbosch University,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,South Africa,Western Cape,Stellenbosch,-33.933162689208984,18.862043380737305,ZA,ZA-WC
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Queen Elizabeth University Hospital,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Glasgow,55.862220764160156,-4.3411111831665039,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,University of Liverpool,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,Liverpool,53.4061164855957,-2.9656040668487549,GB,
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,Boston Children's Hospital,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United States,Massachusetts,Boston,42.337539672851562,-71.105506896972656,US,US-MA
pub.1133359801,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",2020,2020-12-08,The Lancet,MRC Clinical Trials Unit,Elsevier,article,"[grid.7836.a,grid.415052.7,grid.8991.9,grid.418484.5,grid.9481.4,grid.411249.b,grid.411239.c,grid.10025.36,grid.477887.3,grid.11951.3d,grid.420004.2,grid.412563.7,grid.417815.e,grid.451056.3,grid.2515.3,grid.11956.3a,grid.511123.5,grid.31410.37,grid.500643.4,grid.264200.2,grid.11835.3e,grid.5491.9,grid.8532.c,grid.417068.c,grid.439475.8,grid.411233.6,grid.464526.7,grid.512085.b,grid.414449.8,grid.425213.3,grid.5337.2,grid.472984.4,grid.414171.6,grid.5335.0,grid.24029.3d,grid.8756.c,grid.412939.4,grid.430506.4,grid.4991.5,grid.442019.a,grid.1006.7]",1971,1970,13714,United Kingdom,,London,51.517406463623047,-0.12058199942111969,GB,
pub.1128556366,Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections,2020,2020-06-18,Nature Medicine,Second Affiliated Hospital of Chongqing Medical University,Springer Nature,article,"[grid.452206.7,grid.203458.8,grid.412461.4]",1886,1886,13670,China,,Chongqing,29.559755325317383,106.57435607910156,CN,
pub.1128556366,Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections,2020,2020-06-18,Nature Medicine,Chongqing Medical University,Springer Nature,article,"[grid.452206.7,grid.203458.8,grid.412461.4]",1886,1886,13670,China,,Chongqing,29.625120162963867,106.30549621582031,CN,
pub.1128556366,Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections,2020,2020-06-18,Nature Medicine,First Affiliated Hospital of Chongqing Medical University,Springer Nature,article,"[grid.452206.7,grid.203458.8,grid.412461.4]",1886,1886,13670,China,,Chongqing,29.5306396484375,106.51178741455078,CN,
pub.1140976845,SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis,2021,2021-09-08,medRxiv,"University of California, Davis",Cold Spring Harbor Laboratory,preprint,[grid.27860.3b],6,6,13667,United States,California,Davis,38.540000915527344,-121.75,US,US-CA
pub.1125943091,Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma,2020,2020-04-28,JAMA,Shenzhen Third People’s Hospital,American Medical Association (AMA),article,"[grid.410741.7,grid.458513.e]",1659,1659,13615,China,,Shenzhen,22.639060974121094,114.12975311279297,CN,
pub.1125943091,Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma,2020,2020-04-28,JAMA,Tianjin Institute of Industrial Biotechnology,American Medical Association (AMA),article,"[grid.410741.7,grid.458513.e]",1659,1659,13615,China,,Tianjin,39.140525817871094,117.40614318847656,CN,
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,London School of Hygiene & Tropical Medicine,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,Camden,London,51.520900726318359,-0.1307000070810318,GB,GB-CMD
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Western Australia,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,Australia,Western Australia,Perth,-31.980915069580078,115.81987762451172,AU,AU-WA
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,Queen Mary University of London,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,,London,51.5242805480957,-0.040394999086856842,GB,
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Cambridge,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,,Cambridge,52.204452514648438,0.11490800231695175,GB,
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Birmingham,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,,Birmingham,52.450557708740234,-1.930556058883667,GB,
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Bath,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,Bath and North East Somerset,Bath,51.379600524902344,-2.3280000686645508,GB,GB-BAS
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of St Andrews,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,Fife,St Andrews,56.341724395751953,-2.7927629947662354,GB,GB-FIF
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Leeds,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,,Leeds,53.807220458984375,-1.5516669750213623,GB,
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Sussex,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,,Brighton,50.865276336669922,-0.085556000471115112,GB,
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University of Oxford,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1139448905,Mass infection is not an option: we must do more to protect our young,2021,2021-07-07,The Lancet,University College London,Elsevier,article,"[grid.4991.5,grid.5335.0,grid.8991.9,grid.9909.9,grid.4868.2,grid.12082.39,grid.7340.0,grid.83440.3b,grid.11914.3c,grid.6572.6,grid.1012.2]",7,7,13581,United Kingdom,,London,51.524471282958984,-0.13398170471191406,GB,
pub.1136957697,6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records,2021,2021-04-06,The Lancet Psychiatry,Oxford University Hospitals NHS Trust,Elsevier,article,"[grid.410556.3,grid.451190.8,grid.4991.5,grid.511747.1]",321,321,13523,United Kingdom,,Oxford,51.754344940185547,-1.2093130350112915,GB,
pub.1136957697,6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records,2021,2021-04-06,The Lancet Psychiatry,University of Oxford,Elsevier,article,"[grid.410556.3,grid.451190.8,grid.4991.5,grid.511747.1]",321,321,13523,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1136957697,6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records,2021,2021-04-06,The Lancet Psychiatry,Oxford Health NHS Foundation Trust,Elsevier,article,"[grid.410556.3,grid.451190.8,grid.4991.5,grid.511747.1]",321,321,13523,United Kingdom,,Oxford,51.750831604003906,-1.2224999666213989,GB,
pub.1136957697,6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records,2021,2021-04-06,The Lancet Psychiatry,TriNetX (United States),Elsevier,article,"[grid.410556.3,grid.451190.8,grid.4991.5,grid.511747.1]",321,321,13523,United States,Massachusetts,Cambridge,42.395206451416016,-71.147979736328125,US,US-MA
pub.1125152513,Covid-19 — Navigating the Uncharted,2020,2020-02-28,New England Journal of Medicine,National Institutes of Health,Massachusetts Medical Society,article,[grid.94365.3d],967,964,13501,United States,Maryland,Bethesda,39.000442504882812,-77.1023941040039,US,US-MD
pub.1125550328,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",2020,2020-03-11,The Lancet,China-Japan Friendship Hospital,Elsevier,article,"[grid.507952.c,grid.508271.9,grid.24696.3f,grid.415954.8,grid.12527.33]",15581,15573,13216,China,,Beijing,39.974925994873047,116.427001953125,CN,
pub.1125550328,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",2020,2020-03-11,The Lancet,Capital Medical University,Elsevier,article,"[grid.507952.c,grid.508271.9,grid.24696.3f,grid.415954.8,grid.12527.33]",15581,15573,13216,China,,Beijing,39.865432739257812,116.35283660888672,CN,
pub.1125550328,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",2020,2020-03-11,The Lancet,Jinyintan Hospital,Elsevier,article,"[grid.507952.c,grid.508271.9,grid.24696.3f,grid.415954.8,grid.12527.33]",15581,15573,13216,China,,Wuhan,30.66705322265625,114.28695678710938,CN,
pub.1125550328,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",2020,2020-03-11,The Lancet,Tsinghua University,Elsevier,article,"[grid.507952.c,grid.508271.9,grid.24696.3f,grid.415954.8,grid.12527.33]",15581,15573,13216,China,Beijing,Beijing,39.999584197998047,116.32541656494141,CN,CN-11
pub.1125550328,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",2020,2020-03-11,The Lancet,Wuhan Pulmonary Hospital,Elsevier,article,"[grid.507952.c,grid.508271.9,grid.24696.3f,grid.415954.8,grid.12527.33]",15581,15573,13216,China,,Wuhan,30.585750579833984,114.42169189453125,CN,
pub.1133399249,Household Transmission of SARS-CoV-2,2020,2020-12-01,JAMA Network Open,Fred Hutchinson Cancer Research Center,American Medical Association (AMA),article,"[grid.15276.37,grid.34477.33,grid.270240.3]",272,272,13207,United States,Washington,Seattle,47.627288818359375,-122.33107757568359,US,US-WA
pub.1133399249,Household Transmission of SARS-CoV-2,2020,2020-12-01,JAMA Network Open,University of Florida,American Medical Association (AMA),article,"[grid.15276.37,grid.34477.33,grid.270240.3]",272,272,13207,United States,Florida,Gainesville,29.643901824951172,-82.354949951171875,US,US-FL
pub.1133399249,Household Transmission of SARS-CoV-2,2020,2020-12-01,JAMA Network Open,University of Washington,American Medical Association (AMA),article,"[grid.15276.37,grid.34477.33,grid.270240.3]",272,272,13207,United States,Washington,Seattle,47.655536651611328,-122.30352783203125,US,US-WA
pub.1127812395,Remdesivir for the Treatment of Covid-19 — Final Report,2020,2020-10-08,New England Journal of Medicine,University Hospital Cologne,Massachusetts Medical Society,article,"[grid.412484.f,grid.411097.a]",3592,3591,13194,Germany,,Cologne,50.923904418945312,6.9168839454650879,DE,
pub.1127812395,Remdesivir for the Treatment of Covid-19 — Final Report,2020,2020-10-08,New England Journal of Medicine,Seoul National University Hospital,Massachusetts Medical Society,article,"[grid.412484.f,grid.411097.a]",3592,3591,13194,South Korea,,Seoul,37.579372406005859,127.00046539306641,KR,
pub.1129108904,Persistent Symptoms in Patients After Acute COVID-19,2020,2020-08-11,JAMA,Agostino Gemelli University Polyclinic,American Medical Association (AMA),article,[grid.411075.6],1416,1416,13116,Italy,,Rome,41.929752349853516,12.42912483215332,IT,
pub.1138898879,Brain imaging before and after COVID-19 in UK Biobank,2021,2021-06-15,medRxiv,University of Oxford,Cold Spring Harbor Laboratory,preprint,"[grid.7445.2,grid.4991.5,grid.497865.1,grid.416868.5]",26,26,13089,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1138898879,Brain imaging before and after COVID-19 in UK Biobank,2021,2021-06-15,medRxiv,Imperial College London,Cold Spring Harbor Laboratory,preprint,"[grid.7445.2,grid.4991.5,grid.497865.1,grid.416868.5]",26,26,13089,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1138898879,Brain imaging before and after COVID-19 in UK Biobank,2021,2021-06-15,medRxiv,Wellcome Centre for Integrative Neuroimaging,Cold Spring Harbor Laboratory,preprint,"[grid.7445.2,grid.4991.5,grid.497865.1,grid.416868.5]",26,26,13089,United Kingdom,,Oxford,51.765209197998047,-1.2205430269241333,GB,
pub.1138898879,Brain imaging before and after COVID-19 in UK Biobank,2021,2021-06-15,medRxiv,National Institute of Mental Health,Cold Spring Harbor Laboratory,preprint,"[grid.7445.2,grid.4991.5,grid.497865.1,grid.416868.5]",26,26,13089,United States,Maryland,Bethesda,39.003692626953125,-77.104568481445312,US,US-MD
pub.1124462503,Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,2020,2020-01-31,bioRxiv,Indian Institute of Technology Delhi,Cold Spring Harbor Laboratory,preprint,"[grid.8195.5,grid.417967.a]",88,88,13076,India,,New Delhi,28.545000076293945,77.192222595214844,IN,
pub.1124462503,Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,2020,2020-01-31,bioRxiv,University of Delhi,Cold Spring Harbor Laboratory,preprint,"[grid.8195.5,grid.417967.a]",88,88,13076,India,,New Delhi,28.583332061767578,77.166664123535156,IN,
pub.1140108918,Shedding of Infectious SARS-CoV-2 Despite Vaccination,2021,2021-07-31,medRxiv,Wisconsin Department of Health Services,Cold Spring Harbor Laboratory,preprint,"[grid.428370.a,grid.280246.a,grid.512065.5,grid.14003.36]",44,44,12884,United States,Wisconsin,Madison,43.071907043457031,-89.381660461425781,US,US-WI
pub.1140108918,Shedding of Infectious SARS-CoV-2 Despite Vaccination,2021,2021-07-31,medRxiv,Epidemic Intelligence Service,Cold Spring Harbor Laboratory,preprint,"[grid.428370.a,grid.280246.a,grid.512065.5,grid.14003.36]",44,44,12884,United States,Georgia,Atlanta,33.799442291259766,-84.328330993652344,US,US-GA
pub.1140108918,Shedding of Infectious SARS-CoV-2 Despite Vaccination,2021,2021-07-31,medRxiv,Exact Sciences (United States),Cold Spring Harbor Laboratory,preprint,"[grid.428370.a,grid.280246.a,grid.512065.5,grid.14003.36]",44,44,12884,United States,Wisconsin,Madison,43.059646606445312,-89.474372863769531,US,US-WI
pub.1140108918,Shedding of Infectious SARS-CoV-2 Despite Vaccination,2021,2021-07-31,medRxiv,University of Wisconsin–Madison,Cold Spring Harbor Laboratory,preprint,"[grid.428370.a,grid.280246.a,grid.512065.5,grid.14003.36]",44,44,12884,United States,Wisconsin,Madison,43.076694488525391,-89.412437438964844,US,US-WI
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,Graduate Institute of International and Development Studies,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,Switzerland,,Geneva,46.220809936523438,6.1437778472900391,CH,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,French National Centre for Scientific Research,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,France,,Paris,48.847663879394531,2.2640340328216553,FR,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,London School of Economics and Political Science,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,United Kingdom,,London,51.514179229736328,-0.11772000044584274,GB,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,University of Barcelona,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,Spain,,Barcelona,41.386665344238281,2.1638889312744141,ES,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,Paris Dauphine University,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,France,,Paris,48.870018005371094,2.273439884185791,FR,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,University of Oxford,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,Collège de France,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,France,,Paris,48.849716186523438,2.3454899787902832,FR,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,INSEAD,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,France,,Fontainebleau,48.405399322509766,2.68530011177063,FR,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,Paris School of Economics,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,France,,Paris,48.822589874267578,2.3313329219818115,FR,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,Hospital Clínic de Barcelona,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,Spain,,Barcelona,41.388866424560547,2.1511108875274658,ES,
pub.1137568384,"SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",2021,2021-04-28,The Lancet,University of Edinburgh,Elsevier,article,"[grid.424431.4,grid.4444.0,grid.5841.8,grid.410458.c,grid.4991.5,grid.424837.e,grid.424404.2,grid.410533.0,grid.11024.36,grid.13063.37,grid.4305.2]",49,49,12658,United Kingdom,,Edinburgh,55.944896697998047,-3.189284086227417,GB,
pub.1136002305,Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19,2021,2021-04-13,JAMA,University of Valle,American Medical Association (AMA),article,"[grid.8271.c,grid.440787.8,grid.492585.7]",114,114,12585,Colombia,,Santiago de Cali,3.3751089572906494,-76.533538818359375,CO,
pub.1136002305,Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19,2021,2021-04-13,JAMA,Icesi University,American Medical Association (AMA),article,"[grid.8271.c,grid.440787.8,grid.492585.7]",114,114,12585,Colombia,,Santiago de Cali,3.3418169021606445,-76.53082275390625,CO,
pub.1136002305,Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19,2021,2021-04-13,JAMA,Caucaseco Scientific Research Center,American Medical Association (AMA),article,"[grid.8271.c,grid.440787.8,grid.492585.7]",114,114,12585,Colombia,,Santiago de Cali,3.3950643539428711,-76.525665283203125,CO,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Singapore General Hospital,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.2805559635162354,103.83476257324219,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Sengkang General Hospital,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.3956650495529175,103.89337921142578,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Tan Tock Seng Hospital,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.3208099603652954,103.84613037109375,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,National University Health System,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.2923660278320312,103.78343963623047,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Ministry of Health,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.2859549522399902,103.83370208740234,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,National University of Singapore,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.2955559492111206,103.77666473388672,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Nanyang Technological University,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.3447220325469971,103.68138885498047,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Changi General Hospital,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.3417079448699951,103.94956970214844,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,National Centre for Infectious Diseases,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.3221030235290527,103.84720611572266,SG,
pub.1140108861,Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study,2021,2021-07-31,medRxiv,Duke NUS Graduate Medical School,Cold Spring Harbor Laboratory,preprint,"[grid.59025.3b,grid.428397.3,grid.4280.e,grid.508163.9,grid.413815.a,grid.240988.f,grid.410759.e,grid.508077.d,grid.163555.1,grid.415698.7]",86,86,12357,Singapore,,Singapore,1.2825659513473511,103.83402252197266,SG,
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Centro Paulista de Investigação Clinica,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,Brazil,,São Paulo,-23.58997917175293,-46.611106872558594,BR,
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,SUNY Upstate Medical University,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,United States,New York,Syracuse,43.041389465332031,-76.139724731445312,US,US-NY
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Pfizer (United States),Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,United States,New York,New York,40.750362396240234,-73.972541809082031,US,US-NY
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Johns Hopkins University,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,United States,Maryland,Baltimore,39.328887939453125,-76.620277404785156,US,US-MD
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Cincinnati Children's Hospital Medical Center,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,United States,Ohio,Cincinnati,39.140487670898438,-84.501083374023438,US,US-OH
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,BioNTech (Germany),Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,Germany,,Mainz,49.987716674804688,8.2714118957519531,DE,
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Karl Bremer Hospital,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,South Africa,,Cape Town,-33.891513824462891,18.607868194580078,ZA,
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Pfizer (United Kingdom),Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,United Kingdom,Surrey,Tadworth,51.27178955078125,-0.25360798835754395,GB,GB-SRY
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Infant Foundation,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,Argentina,,Buenos Aires,-34.626937866210938,-58.4605712890625,AR,
pub.1140021913,Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,2021,2021-07-28,medRxiv,Hacettepe University,Cold Spring Harbor Laboratory,preprint,"[grid.411023.5,grid.511694.e,grid.21107.35,grid.450252.4,grid.434484.b,grid.14442.37,grid.410513.2,grid.418566.8,grid.239573.9,grid.477499.0]",76,76,12214,Turkey,Ankara,Ankara,39.865516662597656,32.735687255859375,TR,TR-06
pub.1124646670,Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents,2020,2020-02-06,Journal of Hospital Infection,University of Greifswald,Elsevier,article,"[grid.5603.0,grid.5570.7]",1928,1928,11983,Germany,,Greifswald,54.094638824462891,13.374625205993652,DE,
pub.1124646670,Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents,2020,2020-02-06,Journal of Hospital Infection,Ruhr University Bochum,Elsevier,article,"[grid.5603.0,grid.5570.7]",1928,1928,11983,Germany,Nordrhein-Westfalen,Bochum,51.445854187011719,7.2615981101989746,DE,DE-NW
pub.1136760618,"Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021",2021,2021-04-02,MMWR Morbidity and Mortality Weekly Report,University of Arizona,Centers for Disease Control MMWR Office,article,[grid.134563.6],318,318,11848,United States,Arizona,Tucson,32.232246398925781,-110.95354461669922,US,US-AZ
pub.1132012586,COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study,2020,2020-10-26,International Journal of Antimicrobial Agents,Alexion (Germany),Elsevier,article,"[grid.491604.e,grid.411327.2]",47,47,11846,Germany,,Munich,48.143497467041016,11.502118110656738,DE,
pub.1132012586,COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study,2020,2020-10-26,International Journal of Antimicrobial Agents,Heinrich Heine University Düsseldorf,Elsevier,article,"[grid.491604.e,grid.411327.2]",47,47,11846,Germany,,Düsseldorf,51.1967887878418,6.790581226348877,DE,
pub.1140595137,The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines,2021,2021-08-23,bioRxiv,RIKEN Center for Biosystems Dynamics Research,Cold Spring Harbor Laboratory,preprint,"[grid.508743.d,grid.136593.b]",9,9,11777,Japan,,Kobe,34.657886505126953,135.21493530273438,JP,
pub.1140595137,The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines,2021,2021-08-23,bioRxiv,Osaka University,Cold Spring Harbor Laboratory,preprint,"[grid.508743.d,grid.136593.b]",9,9,11777,Japan,,Osaka,34.822288513183594,135.52444458007812,JP,
pub.1132455279,Mobility network models of COVID-19 explain inequities and inform reopening,2020,2020-11-10,Nature,Northwestern University,Springer Nature,article,"[grid.24488.32,grid.499295.a,grid.168010.e,grid.16753.36]",461,461,11683,United States,Illinois,Evanston,42.054851531982422,-87.673942565917969,US,US-IL
pub.1132455279,Mobility network models of COVID-19 explain inequities and inform reopening,2020,2020-11-10,Nature,Microsoft Research (United Kingdom),Springer Nature,article,"[grid.24488.32,grid.499295.a,grid.168010.e,grid.16753.36]",461,461,11683,United Kingdom,,Cambridge,52.194919586181641,0.13490499556064606,GB,
pub.1132455279,Mobility network models of COVID-19 explain inequities and inform reopening,2020,2020-11-10,Nature,Stanford University,Springer Nature,article,"[grid.24488.32,grid.499295.a,grid.168010.e,grid.16753.36]",461,461,11683,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1132455279,Mobility network models of COVID-19 explain inequities and inform reopening,2020,2020-11-10,Nature,CZ Biohub,Springer Nature,article,"[grid.24488.32,grid.499295.a,grid.168010.e,grid.16753.36]",461,461,11683,United States,California,San Francisco,37.765968322753906,-122.38746643066406,US,US-CA
pub.1134385828,Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection,2021,2021-01-06,Science,La Jolla Institute For Allergy & Immunology,American Association for the Advancement of Science (AAAS),article,"[grid.266100.3,grid.185006.a,grid.59734.3c]",1057,1057,11661,United States,California,San Diego,32.877243041992188,-117.22032165527344,US,US-CA
pub.1134385828,Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection,2021,2021-01-06,Science,Icahn School of Medicine at Mount Sinai,American Association for the Advancement of Science (AAAS),article,"[grid.266100.3,grid.185006.a,grid.59734.3c]",1057,1057,11661,United States,New York,New York,40.789085388183594,-73.953109741210938,US,US-NY
pub.1134385828,Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection,2021,2021-01-06,Science,"University of California, San Diego",American Association for the Advancement of Science (AAAS),article,"[grid.266100.3,grid.185006.a,grid.59734.3c]",1057,1057,11661,United States,California,San Diego,32.881000518798828,-117.23799896240234,US,US-CA
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Wuhan Union Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.576213836669922,114.28915405273438,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Tsinghua University,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,Beijing,Beijing,39.999584197998047,116.32541656494141,CN,CN-11
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Beijing University of Chinese Medicine,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Beijing,39.971092224121094,116.42760467529297,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Tongji Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.578750610351562,114.26175689697266,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Capital Medical University,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Beijing,39.865432739257812,116.35283660888672,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Renmin Hospital of Wuhan University,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.536203384399414,114.29827880859375,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Jinyintan Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.66705322265625,114.28695678710938,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,University of Oxford,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Chinese Academy of Medical Sciences & Peking Union Medical College,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Beijing,39.911491394042969,116.41478729248047,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,University of Cambridge,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,United Kingdom,,Cambridge,52.204452514648438,0.11490800231695175,GB,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Shanghai Clinical Research Center,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Shanghai,31.170625686645508,121.41083526611328,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Central Hospital of Wuhan,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.581451416015625,114.29573059082031,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Wuhan Third Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.5402889251709,114.30201721191406,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,University of Virginia,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,United States,Virginia,Charlottesville,38.034999847412109,-78.504997253417969,US,US-VA
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Wuhan Puai Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.593317031860352,114.20511627197266,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Zhongnan Hospital of Wuhan University,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.554094314575195,114.35368347167969,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Wuhan No.1 Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Wuhan,30.572376251220703,114.27188110351562,CN,
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,Lancaster University,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,United Kingdom,Lancashire,Lancaster,54.010746002197266,-2.7903039455413818,GB,GB-LAN
pub.1127239818,"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",2020,2020-04-29,The Lancet,China-Japan Friendship Hospital,Elsevier,article,"[grid.27755.32,grid.412793.a,grid.501233.6,grid.24696.3f,grid.415954.8,grid.460060.4,grid.412632.0,grid.9835.7,grid.506261.6,grid.440160.7,grid.412839.5,grid.410609.a,grid.507952.c,grid.12527.33,grid.413247.7,grid.5335.0,grid.4991.5,grid.452344.0,grid.24695.3c]",2098,2098,11579,China,,Beijing,39.974925994873047,116.427001953125,CN,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,Duke NUS Graduate Medical School,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.2825659513473511,103.83402252197266,SG,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,Institute of Molecular and Cell Biology,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.303104043006897,103.79282379150391,SG,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,National University of Singapore,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.2955559492111206,103.77666473388672,SG,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,National University Hospital,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.2944799661636353,103.78335571289062,SG,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,Singapore General Hospital,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.2805559635162354,103.83476257324219,SG,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,National Centre for Infectious Diseases,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.3221030235290527,103.84720611572266,SG,
pub.1129347263,"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls",2020,2020-07-15,Nature,Singapore Immunology Network,Springer Nature,article,"[grid.412106.0,grid.430276.4,grid.163555.1,grid.508077.d,grid.428397.3,grid.418812.6,grid.4280.e]",964,964,11491,Singapore,,Singapore,1.3058249950408936,103.79646301269531,SG,
pub.1140640450,Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting,2021,2021-08-25,New England Journal of Medicine,Clalit Health Services,Massachusetts Medical Society,article,[grid.414553.2],94,94,11435,Israel,,Tel Aviv,32.079261779785156,34.7719841003418,IL,
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,California Institute of Technology,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,California,Pasadena,34.138576507568359,-118.12549591064453,US,US-CA
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,Fred Hutchinson Cancer Research Center,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Washington,Seattle,47.627288818359375,-122.33107757568359,US,US-WA
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,Stanford University,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,"University of California, Berkeley",American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,California,Berkeley,37.872161865234375,-122.25857543945312,US,US-CA
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,University of Arizona,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Arizona,Tucson,32.232246398925781,-110.95354461669922,US,US-AZ
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,Howard Hughes Medical Institute,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Maryland,Chevy Chase,39.021835327148438,-77.156303405761719,US,US-MD
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,Harvard University,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,University of Basel,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,Switzerland,Basel-Stadt,Basel,47.558578491210938,7.5836000442504883,CH,CH-BS
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,University of Chicago,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Illinois,Chicago,41.788848876953125,-87.598701477050781,US,US-IL
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,University of North Carolina at Chapel Hill,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,North Carolina,Chapel Hill,35.9051628112793,-79.046943664550781,US,US-NC
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,Yale University,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Connecticut,New Haven,41.302093505859375,-72.930656433105469,US,US-CT
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,Broad Institute,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,United States,Massachusetts,Cambridge,42.367889404296875,-71.087028503417969,US,US-MA
pub.1138046097,Investigate the origins of COVID-19,2021,2021-05-13,Science,University of Toronto,American Association for the Advancement of Science (AAAS),article,"[grid.20861.3d,grid.47840.3f,grid.17063.33,grid.270240.3,grid.168010.e,grid.47100.32,grid.413575.1,grid.66859.34,grid.38142.3c,grid.134563.6,grid.6612.3,grid.170205.1,grid.10698.36]",29,29,11395,Canada,Ontario,Toronto,43.661666870117188,-79.3949966430664,CA,CA-ON
pub.1125042614,Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China,2020,2020-04-07,JAMA,Chinese Center For Disease Control and Prevention,American Medical Association (AMA),article,[grid.198530.6],10579,10575,11216,China,,Beijing,39.916240692138672,116.39883422851562,CN,
pub.1138844431,"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness",2021,2021-06-14,The Lancet,Public Health Scotland,Elsevier,article,"[grid.508718.3,grid.4305.2]",341,341,11123,United Kingdom,,Edinburgh,55.931453704833984,-3.2942740917205811,GB,
pub.1138844431,"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness",2021,2021-06-14,The Lancet,University of Edinburgh,Elsevier,article,"[grid.508718.3,grid.4305.2]",341,341,11123,United Kingdom,,Edinburgh,55.944896697998047,-3.189284086227417,GB,
pub.1131627721,Genomic evidence for reinfection with SARS-CoV-2: a case study,2020,2020-10-12,The Lancet Infectious Diseases,Renown Health,Elsevier,article,"[grid.266818.3,grid.272362.0,grid.429897.9]",498,498,11112,United States,Nevada,Reno,39.529109954833984,-119.80160522460938,US,US-NV
pub.1131627721,Genomic evidence for reinfection with SARS-CoV-2: a case study,2020,2020-10-12,The Lancet Infectious Diseases,"University of Nevada, Las Vegas",Elsevier,article,"[grid.266818.3,grid.272362.0,grid.429897.9]",498,498,11112,United States,Nevada,Las Vegas,36.107791900634766,-115.14376068115234,US,US-NV
pub.1131627721,Genomic evidence for reinfection with SARS-CoV-2: a case study,2020,2020-10-12,The Lancet Infectious Diseases,University of Nevada Reno,Elsevier,article,"[grid.266818.3,grid.272362.0,grid.429897.9]",498,498,11112,United States,Nevada,Reno,39.545833587646484,-119.81666564941406,US,US-NV
pub.1126271215,Indoor transmission of SARS-CoV-2,2020,2020-04-07,medRxiv,Tsinghua University,Cold Spring Harbor Laboratory,preprint,"[grid.12527.33,grid.194645.b,grid.263826.b]",107,107,11099,China,Beijing,Beijing,39.999584197998047,116.32541656494141,CN,CN-11
pub.1126271215,Indoor transmission of SARS-CoV-2,2020,2020-04-07,medRxiv,University of Hong Kong,Cold Spring Harbor Laboratory,preprint,"[grid.12527.33,grid.194645.b,grid.263826.b]",107,107,11099,China,Hong Kong,Hong Kong,22.283287048339844,114.13707733154297,CN,CN-91
pub.1126271215,Indoor transmission of SARS-CoV-2,2020,2020-04-07,medRxiv,Southeast University,Cold Spring Harbor Laboratory,preprint,"[grid.12527.33,grid.194645.b,grid.263826.b]",107,107,11099,China,,Nanjing,32.055927276611328,118.79425048828125,CN,
pub.1130674619,Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine,2020,2020-09-08,New England Journal of Medicine,"University of California, San Francisco",Massachusetts Medical Society,article,[grid.266102.1],138,138,11061,United States,California,San Francisco,37.762798309326172,-122.45767211914062,US,US-CA
pub.1128529976,Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US,2020,2020-06-16,Health Affairs,University of Iowa,Health Affairs,article,[grid.214572.7],336,336,11017,United States,Iowa,Iowa City,41.6629524230957,-91.554924011230469,US,US-IA
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Tsinghua University,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,Beijing,Beijing,39.999584197998047,116.32541656494141,CN,CN-11
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Jinyintan Hospital,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Wuhan,30.66705322265625,114.28695678710938,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,China-Japan Friendship Hospital,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Beijing,39.974925994873047,116.427001953125,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Center for Life Sciences,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Beijing,39.917293548583984,116.40158081054688,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Peking University,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,Beijing,Beijing,39.987152099609375,116.30585479736328,CN,CN-11
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Sichuan University,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Chengdu,30.630159378051758,104.09001159667969,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Capital Medical University,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Beijing,39.865432739257812,116.35283660888672,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Harbin Medical University,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,Heilongjiang,Harbin,45.700458526611328,126.62017059326172,CN,CN-23
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,West China Hospital of Sichuan University,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Chengdu,30.643222808837891,104.06109619140625,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Beijing University of Chinese Medicine,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Beijing,39.971092224121094,116.42760467529297,CN,
pub.1134476360,6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,2021,2021-01-08,The Lancet,Chinese Academy of Medical Sciences & Peking Union Medical College,Elsevier,article,"[grid.11135.37,grid.12527.33,grid.507952.c,grid.13291.38,grid.24695.3c,grid.452723.5,grid.415954.8,grid.24696.3f,grid.410736.7,grid.506261.6,grid.412901.f]",1038,1038,10992,China,,Beijing,39.911491394042969,116.41478729248047,CN,
pub.1130573548,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia",2020,2020-09-04,The Lancet,Ministry of Health,Elsevier,article,"[grid.494808.9,grid.415738.c,grid.448878.f]",511,507,10961,Russia,,Moscow,55.765262603759766,37.618602752685547,RU,
pub.1130573548,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia",2020,2020-09-04,The Lancet,Ministry of Defence of the Russian Federation,Elsevier,article,"[grid.494808.9,grid.415738.c,grid.448878.f]",511,507,10961,Russia,,Moscow,55.750144958496094,37.6024055480957,RU,
pub.1130573548,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia",2020,2020-09-04,The Lancet,Sechenov University,Elsevier,article,"[grid.494808.9,grid.415738.c,grid.448878.f]",511,507,10961,Russia,,Moscow,55.728057861328125,37.575000762939453,RU,
pub.1136002316,RETRACTED ARTICLE: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study,2021,2021-03-05,Scientific Reports,Universidade do Vale do Rio dos Sinos,Springer Nature,article,"[grid.412302.6,grid.8532.c,grid.411598.0,grid.414449.8]",15,15,10920,Brazil,,São Leopoldo,-29.795875549316406,-51.154193878173828,BR,
pub.1136002316,RETRACTED ARTICLE: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study,2021,2021-03-05,Scientific Reports,Federal University Foundation of Rio Grande,Springer Nature,article,"[grid.412302.6,grid.8532.c,grid.411598.0,grid.414449.8]",15,15,10920,Brazil,,Rio Grande,-32.072071075439453,-52.171028137207031,BR,
pub.1136002316,RETRACTED ARTICLE: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study,2021,2021-03-05,Scientific Reports,Federal University of Rio Grande do Sul,Springer Nature,article,"[grid.412302.6,grid.8532.c,grid.411598.0,grid.414449.8]",15,15,10920,Brazil,Rio Grande do Sul,Porto Alegre,-30.032438278198242,-51.219314575195312,BR,BR-RS
pub.1136002316,RETRACTED ARTICLE: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study,2021,2021-03-05,Scientific Reports,Hospital de Clínicas de Porto Alegre,Springer Nature,article,"[grid.412302.6,grid.8532.c,grid.411598.0,grid.414449.8]",15,15,10920,Brazil,,Porto Alegre,-30.037975311279297,-51.207469940185547,BR,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Cambridge,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,Cambridge,52.204452514648438,0.11490800231695175,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,London School of Hygiene & Tropical Medicine,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,Camden,London,51.520900726318359,-0.1307000070810318,GB,GB-CMD
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Massachusetts General Hospital,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,Massachusetts,Boston,42.3628044128418,-71.068634033203125,US,US-MA
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Birmingham,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,Birmingham,52.450557708740234,-1.930556058883667,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Icahn School of Medicine at Mount Sinai,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,New York,New York,40.789085388183594,-73.953109741210938,US,US-NY
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Max Planck Institute for Dynamics and Self-Organization,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,Germany,,Göttingen,51.560928344726562,9.96741008758545,DE,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Queen Mary University of London,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,London,51.5242805480957,-0.040394999086856842,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Délégation Régionale Occitanie Pyrénées,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,France,,Toulouse,43.611904144287109,1.4006940126419067,FR,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Southampton,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,Southampton,50.93463134765625,-1.3959499597549438,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Duke University,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,North Carolina,Durham,36.003147125244141,-78.926895141601562,US,US-NC
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Western Australia,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,Australia,Western Australia,Perth,-31.980915069580078,115.81987762451172,AU,AU-WA
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University College London,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,London,51.524471282958984,-0.13398170471191406,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Bath,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,Bath and North East Somerset,Bath,51.379600524902344,-2.3280000686645508,GB,GB-BAS
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Edinburgh,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,Edinburgh,55.944896697998047,-3.189284086227417,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Imperial College London,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Imperial College Healthcare NHS Trust,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,England,London,51.5172119140625,-0.17348499596118927,GB,GB-ENG
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Harvard University,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Federation of American Scientists,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,District of Columbia,Washington D.C.,38.905025482177734,-77.039215087890625,US,US-DC
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Boston University,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,Massachusetts,Boston,42.349601745605469,-71.099700927734375,US,US-MA
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,The Francis Crick Institute,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,,London,51.525485992431641,-0.13545691967010498,GB,
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Oxford,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,Johns Hopkins University,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,United States,Maryland,Baltimore,39.328887939453125,-76.620277404785156,US,US-MD
pub.1131721397,Scientific consensus on the COVID-19 pandemic: we need to act now,2020,2020-10-15,The Lancet,University of Basel,Elsevier,article,"[grid.32224.35,grid.451388.3,grid.457379.b,grid.83440.3b,grid.6572.6,grid.4305.2,grid.433854.d,grid.4868.2,grid.5335.0,grid.1012.2,grid.7340.0,grid.8991.9,grid.7445.2,grid.4991.5,grid.5491.9,grid.417895.6,grid.21107.35,grid.6612.3,grid.419514.c,grid.38142.3c,grid.189504.1,grid.59734.3c,grid.26009.3d]",127,127,10905,Switzerland,Basel-Stadt,Basel,47.558578491210938,7.5836000442504883,CH,CH-BS
pub.1134400305,SARS-CoV-2 Transmission From People Without COVID-19 Symptoms,2021,2021-01-04,JAMA Network Open,Centers for Disease Control and Prevention,American Medical Association (AMA),article,[grid.416738.f],312,312,10836,United States,Georgia,Atlanta,33.7988166809082,-84.325599670410156,US,US-GA
pub.1138297521,SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans,2021,2021-05-24,Nature,Washington University in St. Louis,Springer Nature,article,"[grid.7914.b,grid.4367.6]",139,139,10754,United States,Missouri,St Louis,38.649032592773438,-90.31085205078125,US,US-MO
pub.1138297521,SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans,2021,2021-05-24,Nature,University of Bergen,Springer Nature,article,"[grid.7914.b,grid.4367.6]",139,139,10754,Norway,Hordaland,Bergen,60.388084411621094,5.3228721618652344,NO,NO-12
pub.1138865423,RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article,2021,2021-06-15,The Journal of Antibiotics,Mahatma Gandhi Memorial Medical College,Springer Nature,article,[grid.415481.d],11,11,10746,India,Madhya Pradesh,Indore,22.7105655670166,75.880584716796875,IN,IN-MP
pub.1141613287,Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study,2021,2021-10-04,The Lancet,Kaiser Permanente,Elsevier,article,"[grid.280062.e,grid.19006.3e,grid.410513.2]",130,130,10719,United States,California,Oakland,37.806110382080078,-122.26466369628906,US,US-CA
pub.1141613287,Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study,2021,2021-10-04,The Lancet,Pfizer (United States),Elsevier,article,"[grid.280062.e,grid.19006.3e,grid.410513.2]",130,130,10719,United States,New York,New York,40.750362396240234,-73.972541809082031,US,US-NY
pub.1141613287,Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study,2021,2021-10-04,The Lancet,"University of California, Los Angeles",Elsevier,article,"[grid.280062.e,grid.19006.3e,grid.410513.2]",130,130,10719,United States,California,Los Angeles,34.072223663330078,-118.44409942626953,US,US-CA
pub.1138614686,Necessity of COVID-19 vaccination in previously infected individuals,2021,2021-06-04,medRxiv,Cleveland Clinic,Cold Spring Harbor Laboratory,preprint,[grid.239578.2],14,14,10694,United States,Ohio,Cleveland,41.3841438293457,-81.7184066772461,US,US-OH
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,World Health Organization,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,Switzerland,,Geneva,46.201755523681641,6.14660120010376,CH,
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,University College London,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United Kingdom,,London,51.524471282958984,-0.13398170471191406,GB,
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,Imperial College London,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,Harvard University,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,World Bank Group,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United States,District of Columbia,Washington D.C.,38.899299621582031,-77.0425033569336,US,US-DC
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,University of Oxford,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,University of Cape Town,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,South Africa,,Rondebosch,-33.957500457763672,18.460556030273438,ZA,
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,Boston Children's Hospital,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United States,Massachusetts,Boston,42.337539672851562,-71.105506896972656,US,US-MA
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,Centers for Disease Control and Prevention,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United States,Georgia,Atlanta,33.7988166809082,-84.325599670410156,US,US-GA
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,United States Agency for International Development,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,United States,District of Columbia,Washington D.C.,38.894828796386719,-77.030143737792969,US,US-DC
pub.1139824622,Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study,2021,2021-07-21,The Lancet,University of Copenhagen,Elsevier,article,"[grid.83440.3b,grid.3575.4,grid.484609.7,grid.5254.6,grid.4991.5,grid.416738.f,grid.7836.a,grid.420285.9,grid.7445.2,grid.2515.3,grid.38142.3c]",31,31,10465,Denmark,,Copenhagen,55.679721832275391,12.572500228881836,DK,
pub.1125631203,Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1,2020,2020-03-10,medRxiv,Princeton University,Cold Spring Harbor Laboratory,preprint,"[grid.419260.8,grid.419681.3,grid.16750.35,grid.19006.3e,grid.453035.4]",284,284,10384,United States,New Jersey,Princeton,40.344234466552734,-74.6514663696289,US,US-NJ
pub.1125631203,Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1,2020,2020-03-10,medRxiv,Fogarty International Center,Cold Spring Harbor Laboratory,preprint,"[grid.419260.8,grid.419681.3,grid.16750.35,grid.19006.3e,grid.453035.4]",284,284,10384,United States,Maryland,Bethesda,39.0044059753418,-77.099655151367188,US,US-MD
pub.1125631203,Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1,2020,2020-03-10,medRxiv,National Institute of Allergy and Infectious Diseases,Cold Spring Harbor Laboratory,preprint,"[grid.419260.8,grid.419681.3,grid.16750.35,grid.19006.3e,grid.453035.4]",284,284,10384,United States,Maryland,Bethesda,39.066646575927734,-77.111831665039062,US,US-MD
pub.1125631203,Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1,2020,2020-03-10,medRxiv,National Center for Immunization and Respiratory Diseases,Cold Spring Harbor Laboratory,preprint,"[grid.419260.8,grid.419681.3,grid.16750.35,grid.19006.3e,grid.453035.4]",284,284,10384,United States,Georgia,Atlanta,33.799339294433594,-84.328010559082031,US,US-GA
pub.1125631203,Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1,2020,2020-03-10,medRxiv,"University of California, Los Angeles",Cold Spring Harbor Laboratory,preprint,"[grid.419260.8,grid.419681.3,grid.16750.35,grid.19006.3e,grid.453035.4]",284,284,10384,United States,California,Los Angeles,34.072223663330078,-118.44409942626953,US,US-CA
pub.1139667591,Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview,2021,2021-07-13,medRxiv,Stanford University,Cold Spring Harbor Laboratory,preprint,[grid.168010.e],3,3,10279,United States,California,Stanford,37.430000305175781,-122.16999816894531,US,US-CA
pub.1137252250,First case of postmortem study in a patient vaccinated against SARS-CoV-2,2021,2021-04-16,International Journal of Infectious Diseases,Bielefeld University,Elsevier,article,"[grid.7491.b,grid.412811.f]",5,5,10257,Germany,Nordrhein-Westfalen,Bielefeld,52.037776947021484,8.4930562973022461,DE,DE-NW
pub.1137252250,First case of postmortem study in a patient vaccinated against SARS-CoV-2,2021,2021-04-16,International Journal of Infectious Diseases,Klinikum Region Hannover,Elsevier,article,"[grid.7491.b,grid.412811.f]",5,5,10257,Germany,,Hanover,52.493633270263672,9.4661293029785156,DE,
pub.1142595221,Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa,2021,2021-11-11,medRxiv,University of KwaZulu-Natal,Cold Spring Harbor Laboratory,preprint,"[grid.11951.3d,grid.25073.33,grid.428428.0,grid.416657.7,grid.11956.3a,grid.16463.36]",70,70,10227,South Africa,,Durban,-29.867519378662109,30.980810165405273,ZA,
pub.1142595221,Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa,2021,2021-11-11,medRxiv,Centre for the AIDS Programme of Research in South Africa,Cold Spring Harbor Laboratory,preprint,"[grid.11951.3d,grid.25073.33,grid.428428.0,grid.416657.7,grid.11956.3a,grid.16463.36]",70,70,10227,South Africa,,Durban,-29.859563827514648,31.0103816986084,ZA,
pub.1142595221,Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa,2021,2021-11-11,medRxiv,McMaster University,Cold Spring Harbor Laboratory,preprint,"[grid.11951.3d,grid.25073.33,grid.428428.0,grid.416657.7,grid.11956.3a,grid.16463.36]",70,70,10227,Canada,Ontario,Hamilton,43.263332366943359,-79.918891906738281,CA,CA-ON
pub.1142595221,Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa,2021,2021-11-11,medRxiv,National Health Laboratory Service,Cold Spring Harbor Laboratory,preprint,"[grid.11951.3d,grid.25073.33,grid.428428.0,grid.416657.7,grid.11956.3a,grid.16463.36]",70,70,10227,South Africa,,Johannesburg,-26.131431579589844,28.117898941040039,ZA,
pub.1142595221,Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa,2021,2021-11-11,medRxiv,University of the Witwatersrand,Cold Spring Harbor Laboratory,preprint,"[grid.11951.3d,grid.25073.33,grid.428428.0,grid.416657.7,grid.11956.3a,grid.16463.36]",70,70,10227,South Africa,,Johannesburg,-26.190832138061523,28.030277252197266,ZA,
pub.1142595221,Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa,2021,2021-11-11,medRxiv,Stellenbosch University,Cold Spring Harbor Laboratory,preprint,"[grid.11951.3d,grid.25073.33,grid.428428.0,grid.416657.7,grid.11956.3a,grid.16463.36]",70,70,10227,South Africa,Western Cape,Stellenbosch,-33.933162689208984,18.862043380737305,ZA,ZA-WC
pub.1139867454,Cognitive deficits in people who have recovered from COVID-19,2021,2021-07-23,EClinicalMedicine,King's College London,Elsevier,article,"[grid.5491.9,grid.7445.2,grid.5335.0,grid.13097.3c,grid.170205.1]",39,39,10213,United Kingdom,,London,51.511417388916016,-0.11672700196504593,GB,
pub.1139867454,Cognitive deficits in people who have recovered from COVID-19,2021,2021-07-23,EClinicalMedicine,University of Chicago,Elsevier,article,"[grid.5491.9,grid.7445.2,grid.5335.0,grid.13097.3c,grid.170205.1]",39,39,10213,United States,Illinois,Chicago,41.788848876953125,-87.598701477050781,US,US-IL
pub.1139867454,Cognitive deficits in people who have recovered from COVID-19,2021,2021-07-23,EClinicalMedicine,University of Cambridge,Elsevier,article,"[grid.5491.9,grid.7445.2,grid.5335.0,grid.13097.3c,grid.170205.1]",39,39,10213,United Kingdom,,Cambridge,52.204452514648438,0.11490800231695175,GB,
pub.1139867454,Cognitive deficits in people who have recovered from COVID-19,2021,2021-07-23,EClinicalMedicine,University of Southampton,Elsevier,article,"[grid.5491.9,grid.7445.2,grid.5335.0,grid.13097.3c,grid.170205.1]",39,39,10213,United Kingdom,,Southampton,50.93463134765625,-1.3959499597549438,GB,
pub.1139867454,Cognitive deficits in people who have recovered from COVID-19,2021,2021-07-23,EClinicalMedicine,Imperial College London,Elsevier,article,"[grid.5491.9,grid.7445.2,grid.5335.0,grid.13097.3c,grid.170205.1]",39,39,10213,United Kingdom,Westminster,London,51.498600006103516,-0.175477996468544,GB,GB-WSM
pub.1134198193,Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine,2020,2020-12-30,New England Journal of Medicine,Brigham and Women's Hospital,Massachusetts Medical Society,article,[grid.62560.37],3104,3104,10138,United States,Massachusetts,Boston,42.335601806640625,-71.106414794921875,US,US-MA
pub.1128189014,A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19,2020,2020-06-03,New England Journal of Medicine,Research Institute in Oncology and Hematology,Massachusetts Medical Society,article,[grid.470367.1],864,864,10102,Canada,Manitoba,Winnipeg,49.9030647277832,-97.1583251953125,CA,CA-MB
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,United States Food and Drug Administration,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,United States,Maryland,Silver Spring,39.0352783203125,-76.9830551147461,US,US-MD
pub.1139138448,The Safety of COVID-19 Vaccinations—We Should Rethink the Policy,2021,2021-06-24,Vaccines,Witten/Herdecke University,MDPI,article,"[grid.412581.b,grid.22254.33,grid.415896.7]",6,6,10029,Germany,,Witten,51.452903747558594,7.3562541007995605,DE,
pub.1139138448,The Safety of COVID-19 Vaccinations—We Should Rethink the Policy,2021,2021-06-24,Vaccines,Leopoldina Krankenhaus Schweinfurt,MDPI,article,"[grid.412581.b,grid.22254.33,grid.415896.7]",6,6,10029,Germany,,Schweinfurt,50.051994323730469,10.244346618652344,DE,
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of Oxford,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,United Kingdom,Oxfordshire,Oxford,51.753437042236328,-1.25400972366333,GB,GB-OXF
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of Washington,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,United States,Washington,Seattle,47.655536651611328,-122.30352783203125,US,US-WA
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,INCLEN Trust International,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,India,,New Delhi,28.519248962402344,77.279548645019531,IN,
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,World Health Organization,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,Switzerland,,Geneva,46.201755523681641,6.14660120010376,CH,
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of Bristol,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,United Kingdom,,Bristol,51.456390380859375,-2.6044440269470215,GB,
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of the West Indies System,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,Jamaica,,Kingston,18.005977630615234,-76.746826171875,JM,
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,National Autonomous University of Mexico,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,Mexico,Distrito Federal,Mexico City,19.322816848754883,-99.186630249023438,MX,MX-DIF
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of the Witwatersrand,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,South Africa,,Johannesburg,-26.190832138061523,28.030277252197266,ZA,
pub.1139138448,The Safety of COVID-19 Vaccinations—We Should Rethink the Policy,2021,2021-06-24,Vaccines,Poznan University of Medical Sciences,MDPI,article,"[grid.412581.b,grid.22254.33,grid.415896.7]",6,6,10029,Poland,,Poznań,52.409442901611328,16.918888092041016,PL,
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of Florida,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,United States,Florida,Gainesville,29.643901824951172,-82.354949951171875,US,US-FL
pub.1141106287,Considerations in boosting COVID-19 vaccine immune responses,2021,2021-09-14,The Lancet,University of Paris,Elsevier,article,"[grid.5337.2,grid.417587.8,grid.3575.4,grid.471013.0,grid.11951.3d,grid.4991.5,grid.15276.37,grid.461576.7,grid.34477.33,grid.9486.3,grid.508487.6]",47,47,10029,France,,Paris,48.863807678222656,2.32920503616333,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Centre Méditerranéen de Médecine Moléculaire,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Nice,43.696609497070312,7.2261099815368652,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Méditerranée Infection Foundation,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Marseille,43.289951324462891,5.4006838798522949,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Centre Hospitalier Universitaire de Nice,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Nice,43.710521697998047,7.2605338096618652,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Université Côte d'Azur,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Nice,43.737361907958984,7.0645670890808105,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Hôpital de la Timone,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Marseille,43.290122985839844,5.4040231704711914,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Hôpital l'Archet,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Nice,43.694972991943359,7.2285609245300293,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Aix-Marseille University,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,France,,Marseille,43.293537139892578,5.3579440116882324,FR,
pub.1125793694,Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,2020,2020-03-20,International Journal of Antimicrobial Agents,Thai Binh University of Medicine and Pharmacy,Elsevier,article,"[grid.462370.4,grid.444878.3,grid.413770.6,grid.460782.f,grid.410528.a,grid.483853.1,grid.5399.6,grid.411266.6]",3253,3252,10018,Vietnam,,Thái Bình,20.442117691040039,106.33910369873047,VN,
pub.1128979678,It is Time to Address Airborne Transmission of COVID-19,2020,2020-07-06,Clinical Infectious Diseases,Queensland University of Technology,Oxford University Press (OUP),article,"[grid.164295.d,grid.1024.7]",616,616,9982,Australia,Queensland,Brisbane,-27.476833343505859,153.02839660644531,AU,AU-QLD
pub.1128979678,It is Time to Address Airborne Transmission of COVID-19,2020,2020-07-06,Clinical Infectious Diseases,"University of Maryland, College Park",Oxford University Press (OUP),article,"[grid.164295.d,grid.1024.7]",616,616,9982,United States,Maryland,College Park,38.983047485351562,-76.941864013671875,US,US-MD
pub.1139318237,SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern,2021,2021-07-01,Science,VIR Biotechnology (United States),American Association for the Advancement of Science (AAAS),article,"[grid.34477.33,grid.483007.8,grid.498378.9,grid.507173.7]",135,135,9830,United States,California,San Francisco,37.767074584960938,-122.38785552978516,US,US-CA
pub.1139318237,SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern,2021,2021-07-01,Science,Vir Biotechnology (Switzerland),American Association for the Advancement of Science (AAAS),article,"[grid.34477.33,grid.483007.8,grid.498378.9,grid.507173.7]",135,135,9830,Switzerland,,Bellinzona,46.193943023681641,9.0183353424072266,CH,
pub.1139318237,SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern,2021,2021-07-01,Science,Clinica Luganese Moncucco,American Association for the Advancement of Science (AAAS),article,"[grid.34477.33,grid.483007.8,grid.498378.9,grid.507173.7]",135,135,9830,Switzerland,,Lugano,46.005210876464844,8.93993854522705,CH,
pub.1139318237,SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern,2021,2021-07-01,Science,University of Washington,American Association for the Advancement of Science (AAAS),article,"[grid.34477.33,grid.483007.8,grid.498378.9,grid.507173.7]",135,135,9830,United States,Washington,Seattle,47.655536651611328,-122.30352783203125,US,US-WA
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Arizona Heart Hospital,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Arizona,Phoenix,33.481277465820312,-112.04011535644531,US,US-AZ
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Emory University,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Georgia,Atlanta,33.79278564453125,-84.324012756347656,US,US-GA
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Cedars-Sinai Medical Center,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,California,Los Angeles,34.076286315917969,-118.3809814453125,US,US-CA
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Bakersfield Heart Hospital,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,California,Bakersfield,35.385059356689453,-119.03968811035156,US,US-CA
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Baylor Jack and Jane Hamilton Heart and Vascular Hospital,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Texas,Dallas,32.788475036621094,-96.781112670898438,US,US-TX
pub.1132651649,Ranking the effectiveness of worldwide COVID-19 government interventions,2020,2020-11-16,Nature Human Behaviour,Medical University of Vienna,Springer Nature,article,"[grid.209665.e,grid.7841.a,grid.484678.1,grid.22937.3d,grid.6583.8]",370,370,9818,Austria,,Vienna,48.220001220703125,16.351388931274414,AT,
pub.1132651649,Ranking the effectiveness of worldwide COVID-19 government interventions,2020,2020-11-16,Nature Human Behaviour,Complexity Science Hub Vienna,Springer Nature,article,"[grid.209665.e,grid.7841.a,grid.484678.1,grid.22937.3d,grid.6583.8]",370,370,9818,Austria,,Vienna,48.209297180175781,16.347967147827148,AT,
pub.1132651649,Ranking the effectiveness of worldwide COVID-19 government interventions,2020,2020-11-16,Nature Human Behaviour,University of Veterinary Medicine Vienna,Springer Nature,article,"[grid.209665.e,grid.7841.a,grid.484678.1,grid.22937.3d,grid.6583.8]",370,370,9818,Austria,,Vienna,48.255279541015625,16.431388854980469,AT,
pub.1132651649,Ranking the effectiveness of worldwide COVID-19 government interventions,2020,2020-11-16,Nature Human Behaviour,Santa Fe Institute,Springer Nature,article,"[grid.209665.e,grid.7841.a,grid.484678.1,grid.22937.3d,grid.6583.8]",370,370,9818,United States,New Mexico,Santa Fe,35.70050048828125,-105.90859985351562,US,US-NM
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Baylor University Medical Center,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Texas,Dallas,32.78997802734375,-96.779754638671875,US,US-TX
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Johns Hopkins University,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Maryland,Baltimore,39.328887939453125,-76.620277404785156,US,US-MD
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,University of Turin,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,Italy,Piemonte,Turin,45.066665649414062,7.6890192031860352,IT,IT-21
pub.1132651649,Ranking the effectiveness of worldwide COVID-19 government interventions,2020,2020-11-16,Nature Human Behaviour,Sapienza University of Rome,Springer Nature,article,"[grid.209665.e,grid.7841.a,grid.484678.1,grid.22937.3d,grid.6583.8]",370,370,9818,Italy,Lazio,Rome,41.903839111328125,12.514437675476074,IT,IT-62
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,University of Siena,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,Italy,,Siena,43.319198608398438,11.332795143127441,IT,
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Yale University,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Connecticut,New Haven,41.302093505859375,-72.930656433105469,US,US-CT
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,The University of Texas Health Science Center at Houston,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Texas,Houston,29.703306198120117,-95.4030532836914,US,US-TX
pub.1129933516,Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,2020,2020-08-07,The American Journal of Medicine,Henry Ford Hospital,Elsevier,article,"[grid.21107.35,grid.7605.4,grid.476887.2,grid.47100.32,grid.50956.3f,grid.411588.1,grid.461394.d,grid.189967.8,grid.9024.f,grid.489966.c,grid.413103.4,grid.267308.8]",61,61,9818,United States,Michigan,Detroit,42.368087768554688,-83.085136413574219,US,US-MI
pub.1139974906,Ivermectin for preventing and treating COVID‐19,2021,2021-07-28,Cochrane Database of Systematic Reviews,Charité - University Medicine Berlin,Wiley,article,"[grid.411327.2,grid.411760.5,grid.415970.e,grid.6190.e,grid.6363.0]",24,24,9812,Germany,,Berlin,52.526668548583984,13.379721641540527,DE,
pub.1139974906,Ivermectin for preventing and treating COVID‐19,2021,2021-07-28,Cochrane Database of Systematic Reviews,Royal Liverpool University Hospital,Wiley,article,"[grid.411327.2,grid.411760.5,grid.415970.e,grid.6190.e,grid.6363.0]",24,24,9812,United Kingdom,,Liverpool,53.409439086914062,-2.9641199111938477,GB,
pub.1139974906,Ivermectin for preventing and treating COVID‐19,2021,2021-07-28,Cochrane Database of Systematic Reviews,University of Cologne,Wiley,article,"[grid.411327.2,grid.411760.5,grid.415970.e,grid.6190.e,grid.6363.0]",24,24,9812,Germany,,Cologne,50.928054809570312,6.9286108016967773,DE,
pub.1139974906,Ivermectin for preventing and treating COVID‐19,2021,2021-07-28,Cochrane Database of Systematic Reviews,University Hospital Würzburg,Wiley,article,"[grid.411327.2,grid.411760.5,grid.415970.e,grid.6190.e,grid.6363.0]",24,24,9812,Germany,,Wurzburg,49.801517486572266,9.9537296295166016,DE,
pub.1139974906,Ivermectin for preventing and treating COVID‐19,2021,2021-07-28,Cochrane Database of Systematic Reviews,Heinrich Heine University Düsseldorf,Wiley,article,"[grid.411327.2,grid.411760.5,grid.415970.e,grid.6190.e,grid.6363.0]",24,24,9812,Germany,,Düsseldorf,51.1967887878418,6.790581226348877,DE,
pub.1136817900,The Leading Causes of Death in the US for 2020,2021,2021-05-11,JAMA,National Center for Health Statistics,American Medical Association (AMA),article,[grid.416789.5],94,94,9773,United States,Maryland,Hyattsville,38.969436645507812,-76.951774597167969,US,US-MD
pub.1136817185,SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2,2021,2021-03-31,Circulation Research,Salk Institute for Biological Studies,Wolters Kluwer,article,"[grid.266100.3,grid.250671.7]",74,74,9769,United States,California,La Jolla,32.887149810791016,-117.24620819091797,US,US-CA
pub.1136817185,SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2,2021,2021-03-31,Circulation Research,"University of California, San Diego",Wolters Kluwer,article,"[grid.266100.3,grid.250671.7]",74,74,9769,United States,California,San Diego,32.881000518798828,-117.23799896240234,US,US-CA
pub.1140702585,Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study,2021,2021-08-27,The Lancet Infectious Diseases,Public Health England,Elsevier,article,"[grid.271308.f,grid.415038.b]",93,93,9692,United Kingdom,,London,51.691043853759766,-0.11340100318193436,GB,
pub.1140702585,Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study,2021,2021-08-27,The Lancet Infectious Diseases,MRC Biostatistics Unit,Elsevier,article,"[grid.271308.f,grid.415038.b]",93,93,9692,United Kingdom,,Cambridge,52.17333984375,0.14390000700950623,GB,
pub.1127575580,The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission,2020,2020-05-13,Proceedings of the National Academy of Sciences of the United States of America,National Institute of Diabetes and Digestive and Kidney Diseases,Proceedings of the National Academy of Sciences,article,"[grid.419635.c,grid.25879.31]",544,544,9691,United States,Maryland,Bethesda,39.003627777099609,-77.101066589355469,US,US-MD
pub.1127575580,The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission,2020,2020-05-13,Proceedings of the National Academy of Sciences of the United States of America,University of Pennsylvania,Proceedings of the National Academy of Sciences,article,"[grid.419635.c,grid.25879.31]",544,544,9691,United States,Pennsylvania,Philadelphia,39.952457427978516,-75.193222045898438,US,US-PA
pub.1136223748,Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study,2021,2021-03-09,The BMJ,Somerset Partnership NHS Foundation Trust,BMJ,article,"[grid.9835.7,grid.499548.d,grid.5337.2,grid.500936.9,grid.7372.1,grid.8391.3]",383,383,9684,United Kingdom,,Bridgwater,51.147098541259766,-2.9959149360656738,GB,
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Hospital Clínico San Carlos,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,Spain,,Madrid,40.440380096435547,-3.7195670604705811,ES,
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Harvard University,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,Spain,,Madrid,41.386009216308594,2.1662750244140625,ES,
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Escuela Nacional de Sanidad,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,Spain,,Madrid,40.474903106689453,-3.6938245296478271,ES,
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Harvard–MIT Division of Health Sciences and Technology,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,United States,Massachusetts,Cambridge,42.361778259277344,-71.0869140625,US,US-MA
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Ministry of Health,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,Spain,,Madrid,40.413524627685547,-3.6940751075744629,ES,
pub.1129001510,"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study",2020,2020-07-06,The Lancet,Instituto de Salud Carlos III,Elsevier,article,"[grid.512889.f,grid.466571.7,grid.38142.3c,grid.411068.a,grid.413735.7,grid.413448.e,grid.436087.e]",1132,1132,9684,Spain,,Madrid,40.4756965637207,-3.6900589466094971,ES,
pub.1136223748,Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study,2021,2021-03-09,The BMJ,University of Warwick,BMJ,article,"[grid.9835.7,grid.499548.d,grid.5337.2,grid.500936.9,grid.7372.1,grid.8391.3]",383,383,9684,United Kingdom,Warwickshire,Coventry,52.379436492919922,-1.5615019798278809,GB,GB-WAR
pub.1136223748,Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study,2021,2021-03-09,The BMJ,The Alan Turing Institute,BMJ,article,"[grid.9835.7,grid.499548.d,grid.5337.2,grid.500936.9,grid.7372.1,grid.8391.3]",383,383,9684,United Kingdom,,London,51.530654907226562,-0.1267399936914444,GB,
pub.1136223748,Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study,2021,2021-03-09,The BMJ,Lancaster University,BMJ,article,"[grid.9835.7,grid.499548.d,grid.5337.2,grid.500936.9,grid.7372.1,grid.8391.3]",383,383,9684,United Kingdom,Lancashire,Lancaster,54.010746002197266,-2.7903039455413818,GB,GB-LAN
pub.1136223748,Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study,2021,2021-03-09,The BMJ,University of Exeter,BMJ,article,"[grid.9835.7,grid.499548.d,grid.5337.2,grid.500936.9,grid.7372.1,grid.8391.3]",383,383,9684,United Kingdom,,Exeter,50.737342834472656,-3.5351591110229492,GB,
pub.1136223748,Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study,2021,2021-03-09,The BMJ,University of Bristol,BMJ,article,"[grid.9835.7,grid.499548.d,grid.5337.2,grid.500936.9,grid.7372.1,grid.8391.3]",383,383,9684,United Kingdom,,Bristol,51.456390380859375,-2.6044440269470215,GB,
pub.1127740425,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,2020,2020-05-20,Cell,La Jolla Institute For Allergy & Immunology,Elsevier,article,"[grid.10698.36,grid.266100.3,grid.185006.a,grid.59734.3c]",2040,2036,9675,United States,California,San Diego,32.877243041992188,-117.22032165527344,US,US-CA
pub.1127740425,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,2020,2020-05-20,Cell,"University of California, San Diego",Elsevier,article,"[grid.10698.36,grid.266100.3,grid.185006.a,grid.59734.3c]",2040,2036,9675,United States,California,San Diego,32.881000518798828,-117.23799896240234,US,US-CA
pub.1127740425,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,2020,2020-05-20,Cell,University of North Carolina at Chapel Hill,Elsevier,article,"[grid.10698.36,grid.266100.3,grid.185006.a,grid.59734.3c]",2040,2036,9675,United States,North Carolina,Chapel Hill,35.9051628112793,-79.046943664550781,US,US-NC
pub.1127740425,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,2020,2020-05-20,Cell,Icahn School of Medicine at Mount Sinai,Elsevier,article,"[grid.10698.36,grid.266100.3,grid.185006.a,grid.59734.3c]",2040,2036,9675,United States,New York,New York,40.789085388183594,-73.953109741210938,US,US-NY
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,London School of Hygiene & Tropical Medicine,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,United Kingdom,Camden,London,51.520900726318359,-0.1307000070810318,GB,GB-CMD
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,Tufts University,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,United States,Massachusetts,Medford,42.409828186035156,-71.121940612792969,US,US-MA
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,University of Manchester,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,United Kingdom,Manchester,Manchester,53.467048645019531,-2.23388409614563,GB,GB-MAN
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,London School of Economics and Political Science,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,United Kingdom,,London,51.514179229736328,-0.11772000044584274,GB,
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,Quantified Uncertainty Research Institute,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,United States,California,San Francisco,37.777500152587891,-122.41638946533203,US,US-CA
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,Harvard University,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,United States,Massachusetts,Cambridge,42.377052307128906,-71.116653442382812,US,US-MA
pub.1133568040,Inferring the effectiveness of government interventions against COVID-19,2020,2020-12-15,Science,Australian National University,American Association for the Advancement of Science (AAAS),article,"[grid.5335.0,grid.511874.e,grid.1001.0,grid.38142.3c,grid.429997.8,grid.5379.8,grid.7445.2,grid.8991.9,grid.13063.37,grid.4991.5,grid.5337.2]",309,309,9664,Australia,Australian Capital Territory,Canberra,-35.277801513671875,149.12049865722656,AU,AU-ACT